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ABSTRACT
IMPLICATIONS OF METAL COORDINATION IN DAMAGE AND RECOGNITION OF
NUCLEIC ACIDS AND LIPID BILAYERS
Ana Dreab
Old Dominion University, 2022
Director: Dr. Craig A. Bayse

Metal ions have a myriad of biological functions from structural stability to enzymatic
(de)activation and metabolic electron transfer. Redox-active metals also mediate the formation of
reactive oxygen species which may either cause oxidative damage or protect cellular
components. Computational modeling is used here to investigate the role of (1) metal-ion
binding to antimicrobial peptides, (2) metal-ion removal and disulfide formation on zinc finger
(ZF) proteins, and (3) coordination of thiones/selones for the prevention of metal-mediated redox
damage.
Piscidins, natural-occurring antimicrobial peptides, efficiently kill bacteria by targeting
their membranes. Their efficacy is enhanced in vitro by metal-binding and the presence of
membrane-destabilizing oxidized phospholipids (oxPLs). Molecular dynamics (MD) simulations
are used to model insertion of Ni2+-bound piscidins 1 (P1:Ni2+) and 3 (P3:Ni2+) into lipid bilayers
in the presence and absence of oxPLs. Metallation promotes deeper peptide insertion in the
membrane, and P1:Ni2+ is suggested to interact more with anionic lipid headgroups in the
presence of oxPLs.
The release of Zn2+ from ZF proteins through oxidation of the cysteine thiolates is
associated with inhibition of viral replication, disruption of cancer gene expression, and DNA
repair preventing tumor growth. Multi-microsecond MD simulations were performed to examine
the effect of cysteine oxidation on the ZF456 fragment of transcription factor IIIA and its

complex with 5S RNA. Upon oxidation in the absence of RNA, the individual ZF domains
unfold yielding a globular ZF456 peptide. Oxidation of the RNA-bound ZF456 peptide disrupts
key hydrogen bonding interactions between ZF5/ZF6 and 5S RNA.
The antioxidant properties of sulfur and selenium compounds prevent metal-mediated
(i.e., Fenton chemistry) oxidative damage. The effect of the coordination of sulfur/selenium
derivatives of imidazolidinone (thiones/selones) on the electronic structure and reduction
potential of Fe2+ ions solvated or coordinated to guanine are examined using density functional
theory. The highest occupied molecular orbital (HOMO) for the Fe(II)-aqua complex is metalcentered but localized on the nucleobase in the Fe2+-guanine complex. Complexation of the
thione/selone shifts the HOMO to the sulfur/selenium center suggesting a mechanism for
protection of DNA by sacrificial oxidation of the sulfur/selenium ligand.
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NOMENCLATURE

AL

Area per lipid

Aldo-PC

1-palmitoyl-2-(9′-oxo-nonanoyl)-sn-glycero-3-phosphocholine

AMP

Antimicrobial peptide

ARI

Antibiotic-resistant infection

ATCUN

Amino-terminal copper and nickel motif

Cys

Cysteine

COM

Center of mass

CYX

Cystine residue

DFT

Density function theory

DMPC

1,2-dimyristoyl-sn-glycero-3-phosphocholine

DMPG

1,2-dimyristoyl-sn-glycero-3-phosphoglycerol

DOPC

1,2-dioleoyl-sn-glycero-3-phosphocholine

DSSP

Define secondary structure of proteins

FF

Force field

h(C2-C2)

Hydrophobic thickness

h(P-P)

Headgroup-to-headgroup thickness

HID

Histidine residue protonated at the δ-nitrogen

HIE

Histidine residue protonated at the ε-nitrogen

His

Histidine

HOMO

Highest occupied molecular orbital

KA

Isothermal area expansion (compressibility) modulus
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MCPB

Metal Center Parameter Builder

MD

Molecular dynamics

MM

Molecular mechanics

NBO

Natural bond orbital

NPA

Natural population analysis

OxPL

Oxidized phospholipid

oxZF456

Oxidized zinc finger domains 4, 5 and 6

POPC

1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine

POPE

1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine

POPG

1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol

P1

Piscidin-1

P3

Piscidin-3

P1:Ni2+

Ni2+-bound piscidin 1

P3:Ni2+

Ni2+-bound piscidin 3

QM

Quantum mechanics

redZF456

Reduced zinc finger domains 4, 5, and 6

RMSD

Root mean square deviations

RMSF

Root mean square fluctuations

ROS

Reactive oxygen species

rS/Se

Reducible sulfur and selenium compounds

SCD

Deuterium order parameters

Selones

Selenium derivatives of imidazolidinone

SOD

Superoxide dismutase
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Thiones

Sulfur derivatives of imidazolidinone

TFIIIA

Transcription factor III A

VL

Volume per lipid

WBI

Wiberg Bond Index

ZAFF

Zinc AMBER FF

ZF

Zinc finger

ZF456

Middle zinc fingers of transcription factor III A

ZPE

Zero-point energy

z

Insertion depth

1S/1Se

Imidazole thione/selone

2S/2Se

N-methylimidazole thione/selone

3S/3Se

N,N′-dimethylimidazole thione/selone

4S/4Se

1,4,5-trimethylimidazole thione/selone

5S/5Se

1,3,4,5-tetramethylimidazole thione/selone

ρ

Azimuthal rotation angle

τ

Tilt angle
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CHAPTER I
INTRODUCTION

Metals in Biology

Metals serve various biological functions including facilitation of enzyme catalysis by
aiding the substrate’s positioning and activation for reactions (i), electron transfer (ii), structural
stability (iii), and signaling by binding to ligands and behave as molecular “switches” (iv).1–7
Additionally, redox-active metals (e.g., Fe(II/III), Cu(I/II)) can function as redox centers and
transport oxygen.1–4,8–10 Previous surveys on enzymes with experimentally characterized
structures estimated that 47% of these proteins required metals to function.2,9 Metalloenzymes
predominantly use magnesium (16%), zinc (9%), iron (8%), and manganese (6%) to achieve
their catalytical roles (Figure 1).2,9 Other metals include calcium, cobalt, copper, vanadium,
molybdenum, tungsten, nickel, sodium, and potassium; one enzyme makes use of cadmium.
Oxidoreductases (i.e., dehydrogenases and NAD+ reductases) perform their electron transfer
using mostly iron (81% distribution across the enzyme classes), copper (93%), and molybdenum
and tungsten (81%).2
Sodium, potassium, magnesium, and calcium constitute the biological bulk elements
being greatly abundant.3 Na+ and K+ are generally required for osmotic balance, charge
compensation when bound to anionic functional groups, e.g., of nucleic acids, and enzymatic
catalysis.5,11 Na+ and K+ advance enzyme activation in two distinct modes: type I, where the
______________________________________________________________________________
This Dissertation is formatted based on the Journal of Chemical Information and Modeling.
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Figure 1. Metals used in biological catalysis. The height of the column is proportional to all
enzymes with known structures using the respective metal. Cd is used by a single enzyme.
Reprinted with permission from reference 9.

monovalent cations (M+) bind to the active site of the enzyme connecting it to the substrate and
often work simultaneously with divalent cations (i.e., Mn2+, Mg2+ or Zn2+), and type II, where the
M+ binds at a different site than the active one and induces conformational transitions.12,13
Examples of K+-promoted type I activation assisted by Mg2+ ions include kinases (e.g., pyruvate,
pyridoxal, branched-chain α-ketoacid dehydrogenase, and pyruvate dehydrogenase),14–17
recombinases (e.g., Rad51),12 and phosphatases (e.g., fructose-1,6-bisphosphatase and Sadenosylmethionine synthase)18,19. Class II aldolases, such as fructose- and tagatose-1,6bisphosphate follow a Na+-dependent type I activation paired with Zn2+.20,21 Examples of type II
activation are found in ribokinases (with no discrimination for Na+ or K+),22 pyridoxal 5'phosphate (PLP)-dependent enzymes (e.g., dialkyl glycine decarboxylase, serine dehydratase,
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tryptophanase, tyrosinase, and tryptophan synthase),23–27 thrombin (performed by Na+),28 certain
K+-dependent dehydrogenases,29 and Na/K-ATPase30.
The essential divalent metal ions typically bind to biomolecules according to the Irving–
Williams series (i.e., Mg2+ < Mn2+ < Fe2+ < Co2+ < Ni2+ < Cu2+ (Cu+) > Zn2+), unless steric
hindrance is present.31 Magnesium is important for regulating ion channels, enzymes, signaling
pathways, metabolic cycles, and assisting nucleic acid and protein folding.32,33 DNA polymerases
use Mg2+ for high-fidelity DNA replication.34 Calcium is involved in almost all aspects of cell
function being able to bind reversibly to geometric irregular sites and displaying a fast ligandexchange rate.35 The 1% of Ca2+ not localized in bones as hydroxyapatite or teeth as fluorapatite
can interact with plasma membrane receptors to activate various signaling pathways.3 Ca2+binding proteins belong to two classes that have a different impact on the total cellular content of
Ca2+. The proteins in the first class may act as Ca2+ “sensors” and are responsible for Ca2+
buffering and maintaining the relevant Ca2+ homeostasis.36,37 The second class consists of
membrane proteins that transport Ca2+ across plasma or organelle membranes.36 Some wellknown Ca2+-interacting examples include EF-hand proteins (e.g., calmodulin, S-100,
parvalbumin, and calretinin), C2-domains (e.g., in protein kinase C), annexins, and ATPase.36
Manganese, iron, cobalt, copper, zinc, and molybdenum constitute the trace metals
biologically relevant for humans. Mn is incorporated in several enzymes such as arginase,
phosphoenolpyruvate decarboxylase, and superoxide dismutase (SOD).3 The arginase enzyme
catalyzes the rate-determining step of the urea synthesis and MnSOD is a mitochondrial
metalloprotein that mitigates reactive oxygen species (ROS).38 Iron is an essential micronutrient
whose levels are strictly controlled via a complex endocrine and paracrine system.39,40 Ferric iron
is transported through the blood by the serum protein, transferrin and is intracellularly stored by
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the globular protein, ferritin.41,42 The cytosolic Fe is exported by the transmembrane protein,
ferroportin.43 Among the ~500 human metalloproteins containing Fe, numerous ones have either
a heme prosthetic group (e.g., hemoglobin, myoglobin, and cytochromes) or an Fe-S cluster.39
Within the Fe-containing heme-proteins, hemoglobin and myoglobin transport and store
oxygen;44 cytochromes are responsible for electron transfer and redox catalysis;45 peroxidases
catalyze the oxidation of substrates by hydrogen peroxide;46 and catalases decompose hydrogen
peroxide to water and oxygen.47 Fe-S clusters are structurally and chemically diverse and take
part in a variety of processes including electron transfer, regulation of gene expression and
enzyme activity, substrate binding and activation, and Fe storage.48 Cobalt is mainly encountered
in association with cofactors in cobalamin-dependent enzymes.9 Vitamin-B12 (cyanocobalamin)
is the only human vitamin for that contains metal and is synthesized exclusively by
microorganisms.49 Some prominent enzymes essential for human health that have cobalamin as a
cofactor are methylmalonyl-coenzyme A mutase which helps break down several amino acids,
some lipids and cholesterol, and methionine synthase.50,51
Copper and zinc are catalytic and structural cofactors for a huge number of proteins and
enzymes, and both metals play an important role in the function of the immune system.4,52,53
Similar to Fe, the intracellular bioavailability of Cu is tightly regulated by the transporter (e.g.,
albumins) and chaperone proteins.54 Cu participates in mitochondrial energy (ATP) production
through cytochrome c-oxidase. It offers protection against oxidative stress via Cu/Zn SOD and
supports extracellular matrix stability by covalently crosslinking collagen and elastin via lysyl
oxidase.54 Cu also acts as a cofactor in monooxygenases which catalyze peptide amidation and
maturation,55 amine oxidase which is responsible for the oxidative deamination of primary
amines,56 and coagulation factors V and VIII. Cu, as well as Zn, assist protein folding. Zn
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cellular uptake, distribution, storage, and release are regulated by metallothioneins which have a
high cysteine (Cys) and low aromatic content.5,53 This metal plays a structural role in Zn finger
(ZF) proteins, in which Zn is tetrahedrally coordinated by a combination of Cys and histidine
(His) residues, and a catalytic role in enzymes such as carbonic anhydrase, carboxypeptidase,
alkaline phosphatase, and alcohol dehydrogenases. Many ZF proteins may mediate proteinprotein interactions in addition to binding to nucleic acids.3,53,57
Molybdenum is found mostly in association with cofactors (i.e., FeMo or pterin-based) in
Mo-dependent enzymes.58 This trace element is important for almost all organisms since it is
used by a great variety of enzymes including nitrogenase (bacterial Mo nitrogenase is the only
one that uses FeMo as a cofactor), nitrate reductases, sulfite oxidase, and xanthine
oxidoreductases.59 Nitrate reductase which is not found in animals, is involved in the inorganic
nitrogen assimilation.60 The eukaryotic sulfite oxidase catalyzes the final step in the degradation
of S-containing amino acids (e.g., methionine and taurine), where the sulfite is oxidized to
sulfate.60 The mammalian xanthine oxidoreductases may have dual activity: dehydrogenase and
oxidase, and are involved in purine catabolism.61
Vanadium, nickel, cadmium, and tungsten are only essential for some forms of life.3 W
and Mo share similar chemical features (e.g., atomic, and ionic radii), and W can substitute for
Mo in many prokaryotic enzymes.62 Vanadium is essential for many marine algae, bacteria, and
fungi which contain V-depending haloperoxidases and/or nitrogenases.63 V haloperoxidases use
hydrogen peroxide to catalyze the oxidation of halide ions, and V nitrogenases reduce N2 to NH3
in bacteria.64 Ni-containing enzymes or cofactors occur in archaea, bacteria, unicellular
eukaryotes, and plants.3 Eight Ni enzymes are known to date and all, except glyoxalase I, are
involved in the production and/or use of key gases (i.e., H2, CO, CO2, CH4, NH3, and O2) from
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the global biological carbon, nitrogen, and oxygen cycles.65 Cadmium-carbonic anhydrase is the
only natural occurring enzyme that contains Cd. Additionally, several phytoplankton species
may use a low concentration of Cd2+ ions to enhance their growth under Zn limitations.66
Metal homeostasis is generally highly regulated throughout biology via complex
mechanisms involving metal sensors and chaperones.67 However, dyshomeostasis is presumed to
contribute greatly to pathologies. For example, a high level of Mg2+ in the blood
(hypermagnesemia) results in renal failure, and hypomagnesemia is related to many conditions
including cardiovascular pathologies, hypertension, and alcoholism.3,5 The Cu level in serum
elevates in response to inflammation,68 and nutritional Cu deficiency causes impaired immune
responses, neuropathies, and iron deficiency anemia (Cu is necessary for the absorption of Fe
from the gut).52 Genetic Cu deficiency causes Menkes (mental and physical developmental
impairment), while Cu excess leads to Wilson’s disease (accumulation of Cu in vital organs).69
Aberrant Cu transport has also been associated with Parkinson’s Huntington’s, and Alzheimer’s
diseases.52,70,71 Zn deficiency during pregnancy compromises embryonic, fetal, and postnatal
development giving rise to neurological disorders, immune system dysfunction, and growth
retardation. Impaired Zn absorption is a cause for acrodermatitis enteropathica, a rare recessive
genetic disorder.72 Fe deficiency alters its homeostasis and is related to anemia.39 Increased Fe
absorption from food is known as hereditary hemochromatosis and can result in diabetes or liver
disease, and heart problems as excess Fe is stored in these organs.8 Deficiency of Mo pterinbased cofactor is a rare recessive hereditary disorder that eventually causes the death of the
patients.59 A good and complete understanding of metal homeostasis and sensing would likely
aid in the improved understanding of metal aberrations and in the development of novel
therapies.
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This dissertation focuses on three distinct research topics involving the biological activity
of transition metals. First, Cu2+ and Ni2+ peptide-binding motifs are investigated for their ability
to modify features of antimicrobial peptides in lipid bilayers proposed to enhance membrane
disruptive activity. The second topic focuses on the zinc finger proteins and structural effects of
oxidation of their Zn2+-binding sites as occurs in some promising anticancer and antiviral
treatments. Lastly, Fe2+-mediated oxidative stress and its prevention by sulfur and selenium
compounds are addressed.

The amino-terminal copper and nickel (ATCUN) motif of proteins and peptides

The ATCUN binding unit is a naturally occurring structural motif found in proteins (e.g.,
albumins and protamins) and peptides (e.g., histatin-3/5 and piscidin 1/3) that contain: a free
NH2 terminus (1), a His residue in the third position (2), and two intervening backbone amide
groups (3) (Figure 2).73 The ATCUN-Cu2+ complexes, formed by the high-affinity coordination
of the first three backbone nitrogen and the histidine imidazole-Nδ to Cu2+ in a square planar
geometry, can form reactive oxygen species (ROS) leading to oxidative damage of biological
molecules.73–78 As a result, the ATCUN-Cu2+ motif in proteins/peptides often has nuclease,
protease, and lipase activity which is utilized in protein design for therapeutic purposes.74,76,79
The ATCUN-Ni2+ motif is also effective at cleaving DNA but through a different mechanism
than the ATCUN-Cu2+ complex.73 Additionally, the ATCUN-M2+ derivatives have been
investigated for a large range of biological and chemical applications such as enhanced antitumor
activity,80 enzyme inhibition,81 water oxidation,82 hydrogen evolution,83 nitrite to ammonia
reduction,84 spectroscopic probes, and imaging agents.85
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Figure 2. Schematic representation of the ATCUN motif.

The antimicrobial peptide (AMP) database (https://aps.unmc.edu/database) includes more
than 40 entries for naturally occurring peptides that possess an ATCUN motif, but the role of this
motif in the biological activity of the peptides has not been directly examined for all.86 Synthetic
ATCUN-Cu2+ AMPs have been made to explore the oxidative cleavage activity of the ATCUNM2+ structure, and thus to enhance the antimicrobial activity of the peptides.77,87–89 This
increased activity is believed to be due to the generation of ROS which oxidize the lipids in the
membrane.77,87,88 For example, a correlation was established between the rate of ROS generation
and the extent of lipid oxidation for the ATCUN derivatives of anoplin, a membrane-active
peptide with broad-spectrum antibacterial activity.88 In a time of continued increase in antibiotic
resistance, metalloantibiotic-based AMPs may represent promising novel therapeutics.

Zinc finger (ZF) proteins

Approximately 10% of all proteins encoded in the human genome take part in Zn2+
binding according to bioinformatic studies.90 ZF proteins are a major subset of Zn-binding
proteins and one of the most numerous classes of proteins. ZFs were first discovered in 1985 as
sequence-specific DNA binding motifs in the Xenopus laevis protein transcription factor IIIA
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(TFIIIA).91 The name, zinc fingers, started as laboratory jargon because they incorporated zinc
and gripped DNA.92 Based on the combination of Cys and His residues binding to Zn2+, ZFs can
be divided into three classes: Cys4, Cys2HisCys (Cys3His), or Cys2His2 (Figure 3).93,94 The
apoprotein binds Zn2+ ions only in a tetrahedral coordination geometry which offers increased
stabilization to the ZF cores compared to other metal ions bound to the same cores. Nonetheless,
since Cys binding to Zn2+ is entropically driven causing the stability of the ZF core to be more
susceptible to temperature, pH, and ionic strength, the overall reactivity of ZFs is enhanced.95
For example, the substitution of Zn2+ by other metal ions can lead to incomplete metal
coordination or Cys oxidation.95 Interactions with reactive oxygen or nitrogen species, reducible
sulfur/selenium (rS/Se) compounds, and with other cellular oxidants cause the oxidation of Cys
thiolates and subsequent release of Zn2+. In the absence of the key structural metal ion, the

Figure 3. Graphical representation of domain folds and metal coordination within single-ZF
proteins. (A) Cys2His2 ZF from ZNF478 (PBD: 2yrh), (B) Cys2HisCys (gag knuckle) from HIV1 NCp7 (PDB: 2l44), (C) Cys3His ZF from tristetraprolin (PDB: 1m90), (D) Cys4 (zinc ribbon)
from TIF 2 (PDB: 1k81). β-sheets, α-helixes, and Zn2+ ions are colored in blue, green, and red,
respectively. Adapted with permission from reference 95.
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tertiary structure of the ZF protein unravels leading to the loss of ZF functions.
Zn2+ release is associated with disruption of gene expression and DNA repair, which can
prevent tumor growth. For example, both ebselen and selenite inhibit DNA binding by TFIIIA,
SP1, and NF-κβ in vitro.96,97 Combined inhibition in vivo of ZFs may explain ebselen’s
autoinflammatory and anti-cancer effects.96 Recently, disulfiram and ebselen were shown to eject
Zn2+ from the multiprotein SARS-CoV2 replication and transcription complex (i.e., nsp10,
nsp13, and nsp14) and inhibit SARS-CoV-2 replication when combined with remdesivir.98,99
Thus, targeting specific ZF proteins may be a selective way to fight viral infections and cancer.
The mechanism of Zn2+ release by rS/Se oxidants involves an initial electrophilic attack of the
rS/Se compounds (represented as RE–X, E = S, or Se) on a ZF Cys sulfur (Figure 4). A
sulfenated/selenenated intermediate is formed following the transfer of RE+ to the Cys and loss
of X-. In the case of the weaker electrophiles, a chalcogen bonded donor-acceptor intermediate
may be formed along this pathway.100 The ZF undergoes (1) internal Cys attack to form an
intramolecular disulfide bond (oxZF) with the release of RE- and/or (2) sulfen-/selenenation of
the remaining Cys by additional rS/Se equivalents. The softer rSe compounds interact more
strongly than their sulfur counterparts while the reactivity of ZF models decrease in the series:
Cys4 > Cys2HisCys > Cys2His2.100–102
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Figure 4. Mechanism of Zn2+ release from ZF proteins by rS/Se compounds (RE–X) with
examples of sulfen−/selenenating groups (RE+, shown in the inset). Reprinted with permission
from reference 100.

Metal-mediated ROS generation and Oxidative Stress

Elevated intracellular amounts of ROS are linked with (1) oxidative stress which causes
DNA, protein, and lipid damage, and (2) redox biology, where ROS are used as signaling
molecules to initiate biological processes. Usually, a small increase in ROS levels refers to redox
biology, whereas a high ROS level is defined as oxidative stress and has been associated with
numerous pathologies such as inflammatory and neurodegenerative diseases, carcinogenesis,
diabetes, and aging.103,104 ROS classification includes both free radicals (i.e., O2·-, CO3·-, ·OOH,
·OH, ·OOR, and ·OR), and non-radical compounds (i.e., H2O2, 1O2, HOCl, and O3) among
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which hydrogen peroxide (H2O2) is a major oxidant in living organisms. H2O2 produces hydroxyl
radical, the most damaging ROS, through the Fenton or Fenton-like reaction (eq. 1).104 This
reaction could be the cause of toxicity for some transition metals including iron, the most
abundant transition metal in the human body. In addition to Fe2+, several other metal ions (Cu+ is
probably the next most common ion, followed by Ni2+, Co2+, Ti3+, Cr4+, and Cr5+) can drive the
Fenton reaction in the absence of chelators, which can either inhibit or enhance the reaction.105
Under stress conditions, the superoxide radical anion, a primary ROS product, reduces Fe3+ and
subsequently releases Fe2+ ions from Fe-bound biological molecules (eq. 2) which can further
participate in the Fenton reaction.104
Mn+ + H2O2 → M(n+1)+ + OH- + ·OH

(1)

M(n+1)+ + O2·- → Mn+ + O2

(2)

The metal ions are sequestered and stored in the cells such that their availability to
generate ROS is minimal under normal conditions. The cells also have complex antioxidant
regulatory systems to maintain appropriate ROS homeostasis. Despite this, disruption in proper
ROS balance leading to oxidative stress and tissue injury still occurs.106,107 Chelating drugs have
been developed to prevent the excess of free metal ions and their associated toxicity. Among
these chelators, desferrioxamine B and deferiprone are used as iron reducers (i.e., bind and
remove iron from the bloodstream) in hemochromatosis and β-thalassemia,108,109 while
penicillamine and tetrathiomolybdate are used as copper reducers to treat Wilson’s disease110.
The copper depletion property of tetrathiomolybdate is also being explored in phase II clinical
studies as a way to impair breast cancer metastasis.111 Sulfur and selenium antioxidant
complexes have been studied for the prevention of metal-mediated ROS formation and
ultimately disease treatment or prevention.107
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In this dissertation, three different aspects of metal ions in biology are addressed. First,
Ni2+ ions have been shown to increase the efficacity of AMPs. All-atom molecular dynamics
(MD) simulations are used to model the ability of ATCUN-Ni2+ piscidins 1 and 3 to insert and
permeabilize lipid bilayers, which are mimics of the bacterial membrane. Due to the capability of
the ATCUN-Ni2+ complex to oxidize lipids in membranes,112 and the experimental evidence that
these oxidation products are relevant for some bacteria,113,114 lipid bilayer systems with and
without oxidized phospholipids (oxPLs) have been considered in the current investigation. The
study of piscidins could facilitate the understanding of the mechanism of action of other
metallopeptides that share similar features and help to design novel therapeutics for antibioticresistant infections. Second, the effects of oxidative removal of Zn2+ (coinciding with the
formation of disulfide bonds) from ZF proteins and the interactions of oxidized ZFs with nucleic
acids are examined at the atomistic level. Targeting ZF proteins involved in the survival and
progression of cancer cells or part of viral replication and transcription mechanisms serves as a
promising strategy for cancer treatment or viral inhibition.98,115–117 Disulfide bond formation
induces significant conformational changes in the free protein that inhibit RNA binding. In the
oxidized ZF-RNA complex, the loss of major hydrogen bonds important to RNA recognition
may lead to the dissociation of the oxidized ZFs. Finally, the prevention of Fe2+-mediated DNA
damage by imidazole-based thiones and selones coordination is investigated through DFT
studies of the free ligands and their complexes with Fe2+ coordinated to water and guanine. Metal
coordination has been suggested as the primary mechanism of thiones/selones to prevent DNA
damage.118–121 Thus, protection is expected to occur through sacrificial oxidation of the
coordinated thione/selone122,123 rather than through the direct ROS scavenging observed for other
sulfur and selenium compounds.124–126
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Computational methods

To address the aforementioned research problems, molecular mechanics and quantum
mechanics computational methods are used in this dissertation.
Molecular Mechanics (MM) is an inexpensive technique to compute the potential energy
surface for arrangements of atoms using classical Newtonian mechanics. The potential energy of
a chemical system in each conformation is approximated from the sum of the bonded
(intramolecular) and nonbonded (intermolecular) terms (eq. 3-5).127,128
Etotal = Ebonded + Enonbonded
2

(3)

2

Ebonded = ∑bonds k r (r − req ) + ∑angles k θ (θ − θeq ) + ∑dihedrals
A

B

Vn
2

(1 + cos(nϕ − γ)

qq

ij
Enonbonded = ∑i<j [R12
− Rij6 ] + ∑i<j [ εRi j]
ij

ij

ij

(4)

(5)

The bonded terms (eq. 4) include the bond stretching, angle bending, and dihedral energies,
whereas the nonbonded interactions between all-atom pairs (eq. 5) include the van der Waals
energy computed using the classical Lennard-Jones 6-12 potential,129 and the electrostatic energy
described by the Coulomb potential. Each atom in MM is represented by a particle with defined
mass and radius, the chemical bonds between atoms are modeled as springs, and torsion angles
are computed as an energy approximation between eclipsed and staggered conformations using a
sinusoidal function. The bond stretching and angle bending terms each required a reference or
equilibrium value (req and θeq) and a force constant (kr and kθ). These parameters along with
partial atomic charges (qi and qj) and van der Waals atomic radii need to be parameterized to fit
quantum mechanical calculations and/or experimental data for better behavioral reproduction of
real molecules in motion.128 The collection of empirical parameters and the potential energy
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function is described as a force field (FF). Numerous force fields have been developed over the
years for different types of molecules (e.g., organics, biomolecules, inorganics) and many of
them continue to be in use today including MM3,130 MMFF,131 OPLS,132 AMBER,133 and
CHARMM134.
In this dissertation, AMBER FFs are used to model metal-bound peptides (piscidins) and
proteins (ZFs) in the presence of lipid mixtures and nucleic acids, respectively, to gain atomiclevel insights into the importance of metal-binding to their specific mechanisms of action. The
common FFs are designed for general organic molecules (e.g., GAFF),135 and macromolecules
such as proteins (e.g., ff14SB),136 nucleic acids (e.g., OL3),137 and lipids (e.g., lipid17)138 that
contain standard residues (e.g., the 20 amino acids and particular phospholipids only). None of
these FFs are suitable for modeling non-standards residues such as oxPLs or metal-binding sites
including the ATCUN-Ni2+ complex and Cys2Hys2-Zn2+ ZFs. Due to the multiple coordination
modes of the transition metals and the numerous potential ligands, it becomes challenging to
model metal complexes, especially if unique FFs are required for each metal complex.139 Three
main approaches have been developed to include metal ions into FFs (Figure 5).140 The bonded
model describes bonds, angles, and torsions between the metal ion and its ligating residues, and
the van der Waals constituent of the nonbonded energy function (eq. 5).141 The nonbonded model
treats the interactions purely via electrostatic and Lennard-Jones terms placing integer charge on
the metal ion.142 The cationic dummy atoms model uses dummy atoms (cations) to mimic the
valence electrons around the metal ion, and the interactions between the dummy atoms and
ligands are described as in the nonbonded model.143,144 Various variations and combinations of
the three basic models exist, and multiple automated procedures for the generation of parameters
for inorganic coordination chemistry have been developed over the years.145–147

16

Figure 5. Schematic representations of three approaches that incorporate metals into MM force
fields: (left) the bonded model, (middle) the nonbonded model, and (right) the cationic dummy
atom model. Adapted with permission from reference 147.

The python-based Metal Center Parameter Builder (MCPB) computer program139 was
used to develop the FF parameters for the ATCUN-Ni2+ complex in this study. This program is
based on the bonded plus electrostatic approach which fits perfectly with the form of other
AMBER FFs (see eq. 4-6).147 MCPB helps to derive parameters for metal sites from quantum
mechanical calculations using (1) a smaller model to obtain the bond and angle parameters
associated with the metal, and (2) a larger model to calculate the partial charges based on the
restrained electrostatic potential.139,147 To imitate the chemical environment at an affordable
computational cost, the smaller model and the larger one were chosen to coincide for our system
and includes the Ni2+ ion, the backbone atoms (C, O, N and H) of the first two ATCUN residues,
and the backbone and side chain of His3 capped with NH-CH3 group. For the modeling of
Cys2Hys2-Zn2+ ZFs, Zinc AMBER FF (ZAFF) was successfully applied. ZAFF is intended for
the modeling of four-coordinated Zn metal centers and was developed with the release of the
MCPB program, hence a bonded-based FF.147 The MCPB based parameters were chosen for the
metal-binding sites in the current study because (1) it has been widely and successfully used in
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the literature,148–152 and (2) other approaches (e.g., nonbonded model) have failed to maintain the
proper geometry of the Cys2Hys2-Zn2+ site in test simulations.
The major application of MM force fields is in molecular dynamics (MD), a simulationbased approach that studies the temporal evolution (trajectory) of a set of interacting atoms by
solving Newton’s law
𝐹𝑖 = 𝑚𝑖 𝑎𝑖 .

(6)

Here, 𝑚𝑖 and 𝑎𝑖 are the mass and acceleration, respectively, of the atom, and 𝐹𝑖 is the force
acting upon it. The force of an atom can also be computed as the energy derivative with respect
to the change in the atom’s position (eq. 7).
𝑑𝐸

𝐹𝑖 = 𝑚𝑖 𝑎𝑖 = − 𝑑𝑟

𝑖

(7)

Thus, the position of each atom along a series of discrete time steps (e.g., 1 or 2 fs) can be
determined by using the known atomic forces and masses. The velocities are calculated from the
acceleration according to eq. 8, from which the positions are finally calculated (eq. 9)
𝑎𝑖 =
𝑣𝑖 =

𝑑𝑣𝑖
𝑑𝑡
𝑑𝑟𝑖
𝑑𝑡

(8)
(9)

In summary, at each step of this procedure, the forces acting on the atoms are computed and used
with the current positions and velocities to generate new positions and velocities at the time step
ahead. The atoms are then advanced to new positions and the dynamics cycle is reiterated.153 To
integrate these equations of motion, several numerical algorithms, such as the Leapfrog and
Verlet algorithms, have been generated.
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MD simulations are usually carried out on computer clusters or supercomputers making
use of multiple parallel processors because of the billions of iterations required to generate the
desired trajectories. Common MD packages may have the same name as their default force fields
such as AMBER,154 CHARMM,134 and NAMD,155 or lacking one on its own, support a variety of
force fields, such as GROMACS156 that has implemented AMBER, CHARMM, GROMOS, and
OPLS force fields. Complex, dynamic processes occurring in biological systems can be
investigated by performing MD simulations. Protein folding and stability under various
conditions (pH, temperature, ionic strength), conformational changes, drug design, and
molecular recognition between proteins, nucleic acids, membranes, or metal complexes are a few
such applications.
MD simulations of ZF protein – RNA complexes provide insights into the conformational
changes of the protein upon oxidation and their impact on the key protein-RNA interactions. The
effect of oxidation on protein structure is evaluated by calculating root mean square (RMS)
deviations, atomic RMS fluctuations, and radius of gyration profiles using CPPTRAJ,157 the
main AMBER program for trajectory processing. Additionally, statistical analysis is performed
using the TimeScapes package.158 The change in protein-RNA interactions is determined by
tracking (non)native contacts and hydrogen bond analysis. MD simulations of free and Ni2+bound piscidin P1 and P3 in mixed lipid bilayer deliver atomic insights into the piscidin mode of
action. Peptide-bilayer systems are assembled using the Membrane Builder module in
CHARMM-GUI,159 a popular tool to build lipid bilayers. Structural properties of the simulated
bilayers, such as area per lipid, isothermal area compressibility modulus, lipid order, and bilayer
thickness are determined using CPPTRAJ routines and in-house python and bash scripts. Peptide
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position and orientation into the bilayer are described in terms of the tilt angle, azimuthal angle,
and insertion depths.
Quantum Mechanics (QM) was developed as a new mechanics required to describe a
microscopic system of dual nature (wavelike and particle-like properties). The fundamental
postulate of QM is that the operators acting upon a wave function (Ψ), which exists for any
chemical system return the observable properties of the system. The system energy (E) is
returned as an eigenvalue by the Hamiltonian operator (H) and gives the Schrödinger equation:
HΨ = EΨ. The Hamiltonian depends on both the positions and nuclei atomic numbers, and the
total numbers of electrons. Density functional theory (DFT) evolved as a new method of
obtaining a more accurate approximate solution to the Schrödinger equation for a many-body
system without referencing a wave function. The first attempt to define a DFT used ThomasFermi equations in combination with an assumed variational principle. DFT emerged as a valid
quantum chemical methodology when the Hohenberg-Kohn existence and variational theorems
were defined. According to these theorems, the structural and electronic properties of many-body
systems can be described by using functionals of the electron density. As DFT functionals and
computer power have improved, the applications of DFT in areas of material science,
computational physics, and chemistry have been growing in the last few decades.
In this dissertation, DFT geometry optimizations are performed on free ligands and their
complexes with Fe(II) coordinated to water and guanine using the mPW1PW91 exchangecorrelation functional160,161. The trends in the zwitterionic properties of the free ligand and their
correlation with the complex stability are estimated by calculation of the Wiberg bond indices
(WBIs)162 and Natural Population Analysis (NPA) charges using Natural Bond Orbital (NBO)
analysis163 as implemented in the Gaussian 09 software package164. Wiberg bond order measures
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the electron population overlap between two atoms. NBO analysis serves as a method to analyze
hybridizations and covalency effects in polyatomic molecules. In NBO, the original basis set
goes through a series of transformations to various localized basis sets: natural atomic orbitals,
hybrid orbitals, bond orbitals, and localized molecular orbitals.163
In summary, the goal of this dissertation is to rationalize the role of metal ions in varying
aspects of cell life using MD simulations and DFT calculations by characterizing the atomic
changes upon addition or removal of metal ions, and the possible mechanism of protection in
case of dyshomeostasis. The dissertation is divided into three chapters:
•

Chapter 2 discusses the effect of metal binding and oxidized lipids incorporation on the
membrane activity of piscidin 1 and 3

•

Chapter 3 addresses the conformational changes of free and RNA-bound ZFs upon
removal of metal ion

•

Chapter 4 estimates the prevention of metal-mediated DNA damage by thione/selone
compounds through DFT calculations.
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CHAPTER II
THE EFFECT OF METAL BINDING AND OXIDIZED LIPIDS INCORPORATION ON
THE MEMBRANE ACTIVITY OF ANTIMICROBIAL PEPTIDES

Introduction

Antibiotic-resistant infections (ARIs) affect 2.8 million Americans annually and claim
more than 35,000 lives according to the 2019 CDC’s Antibiotic Resistance Threats report.165
ARIs are particularly dangerous for infection-prone patients such as those with chronic
conditions or receiving chemotherapy, dialysis treatment, or an organ transplant. Due to the lack
of effective drugs, tens of billions of dollars are spent each year on excess healthcare costs.165,166
Despite the effort to reduce infection and death related to ARIs, the spread of new resistance
forms and the number of antibiotic-resistant patients remain high. Increased risk of ARIs is of
great concern because their spread is challenging to identify and contain, which jeopardizes the
patients. More work is required to treat high-risk patients and develop novel therapeutics with
low induction of bacterial resistance. Without urgent action, the estimated global death because
of multi-drug resistance could reach 10 million by 2050.167
Antimicrobial peptides (AMPs) are promising alternatives to conventional antibiotics
because they are considered safe, unlikely to induce bacterial resistance, and have a low risk of
accumulation in tissue. AMPs are a diverse group of synthetically designed or naturally
occurring peptides that contribute to natural immune responses.168 The AMP Database contains
over three thousand AMPs, most of which are cationic and have fewer than fifty amino acids.169
AMPs can be classified into four classes based on their secondary structure: α-helical, β-sheet,
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loop, and extended peptides, with most of them belonging to the first two categories.170–173 αHelical AMPs are unstructured in aqueous solutions but develop an amphipathic helical structure
in the presence of membranes or organic solvents.168,174,175 β-Sheet AMPs, which have a more
defined structure in solution, do not experience significant conformational changes upon
interaction with the bacterial membranes.169,170 The first AMP to be identified was gramicidin
which was isolated from a soil gram-positive bacterial strain of Bacillus brevis in 1939 and
shown to be active against gram-positive bacteria.176–178 Subsequently, numerous AMPs have
been discovered and characterized.179 In 1956, the first animal AMP, phagocytin, was isolated
from rabbit leucocytes.180 The research interest in these peptides really began to grow with the
isolation of defensins and cathelicidins from mammals in the 1980s. The former display
antibacterial, antiviral, and antifungal activities via diverse modes of action.181,182 Over time
many AMPs have been discovered, many of which are used as therapeutics in the market or are
under clinical trials.171
AMPs inactivate invading pathogens rapidly and non-specifically. The AMPs containing
cationic residues bind with high affinity to the surfaces of bacterial membranes which are rich in
anionic phospholipids. The mammalian cell membranes on the other hand consist of zwitterionic
phospholipids and interact with low affinity with the AMPs. The electrostatic interactions of
AMPs with the bacterial membrane surface disrupt the membrane integrity yielding to leakage of
the cell content and eventually, cell death.168,170 Few mechanisms for membrane disruption,
including the barrel-stave, toroidal pore, and carpet model (Figure 6), have been proposed and
are based on experiments with model membranes.171,183,184 These modes of action are not
mutually-exclusive, and AMPs can combine multiple mechanisms to kill their targets.
Additionally, AMPs may achieve membrane permeabilization by decreasing/increasing the
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membrane thickness, clustering the phospholipid headgroups, or translocating the membrane and
targeting specific intracellular molecules or processes.185–187 The latter is known as a nonmembrane disruptive pathway to kill foreign microbes. The chosen mode(s) of action may
depend on parameters such as species and tissue localization of the target pathogen, or local
environment and concentration of the peptide.170,184,188 In addition to broad-spectrum
antibacterial and antifungal activity, many have complex immunomodulatory functions and
synergistic interactions with conventional antibiotics.171 These properties offer AMPs a great
advantage over traditional antibiotics in the fight against infectious diseases. So far, five
naturally occurring AMPs have been approved for clinical use as an alternative to antibiotics due
to their antimicrobial potency.168 Moreover, their cationic analogs constitute the bulk of hundreds
of AMPs that are under clinical evaluation. Several peptides failed to display increased efficacy
over conventional treatment, and/or presented pharmacokinetics and safety concerns which
resulted in the discontinuation of their clinical studies.168 However, an analysis carried out by
Lau et al. on all peptides from human clinical trials revealed that peptides are more successful
than small-molecule drugs regardless of the clinical study’s stage.189
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Figure 6. Models of membrane disruption by AMPs. Adapted from reference 168.
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Figure 7. Selective structural representations of the piscidins included in the current study. (A)
Color-coded helical wheel of P1 adapted with permission from reference 190. The more polar
residues are colored in green, while the hydrophobic ones are in yellow. His and Gly residues are
indicated in blue and gray, respectively. (B) P3 secondary structure with the side chains widely
extended. (C) The ATCUN-Ni2+ motif.
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Piscidins, the α-helical AMPs residing in the mast cells of fish,191 were shown to
efficiently kill bacteria within minutes by targeting their membrane instead of specific cellular
targets.192 As with other AMPs, they function by permeating and weakening the membrane in a
concentration-dependent manner.193,194 Piscidins are believed to bind to the bacterial membrane
first, a process driven both by electrostatic and hydrophobic interactions. The amphipathic
structure of the peptides allows them to insert into the bacterial membrane and induce changes in
the membrane structure and organization. These modifications lead to membrane
permeabilization and eventual bacterial death.195–197 Piscidin 1 (P1,
FFHHIFRGIVHVGKTIHRLVTG) and piscidin 3 (P3, FIHHIFRGIVHAGRSIGRFLTG) are
naturally occurring isoforms discovered in mast cells of hybrid striped sea bass.191,198 These
broadly studied peptides assume an amphipathic, α-helical structure (Figure 7) in the presence of
membranes to maximize their interactions with phospholipids. P1 and P3 have 22 residues and
share 68% sequence identity including three histidine residues (H3, H4, and H11).192 The
histidine (His) residues are important for metal-binding and attraction to the cell membrane.190,196
P1, with an additional His in position 17 (H17), is one of the most potent AMPs and is also
effective against cancer and HIV.192,199–202 P3, the less hemolytic isoform, has a nuclease activity
against bacterial DNA but display a lower rate of killing bacteria (1h vs minutes).192,195 Neutron
diffraction and MD revealed that P1 inserts into the membrane through its C-terminal end, the
hydrophilic extremity carrying H17, whereas P3 directs its N-terminal end toward the bilayer
interior.190 Additionally, the histidines of P1 insert more deeply into the lipid bilayer than those
of P3 as shown by computational modeling.196
Piscidins' antimicrobial potency has been attributed to the atypically large number of His
residues in such a short peptide and an Amino Terminal Cu(II)- and Ni(II)- binding (ATCUN)

26
motif of consensus sequence XXH at the N-terminal end of the peptide (Figure 7C).75,78,203 This
motif is not the same for the two isoforms (FFH- for P1 vs FIH- for P3) but both bind Cu2+ and
Ni2+ ions with high affinity. Formation of the bulky ATCUN-Cu2+/Ni2+ complex upon metal
binding to the ATCUN motif (metallation) is believed to lower the overall charge of piscidin by
1 through deprotonation of the N-terminal ammonium group (coordination of the +2-metal ion is
countered by the loss of the F2 and H3 backbone hydrogens). This net loss of charge could
explain the increase in antimicrobial capacity.73,204 Experimentally, the effect of metallation was
tested using dye leakage assays, a standard experiment for measuring the extent of damage
induced by external agents (i.e., piscidins) on synthetic lipid vesicles (bacteria mimics).190
Metallated P1 showed a five-fold increase in permeabilization effectiveness measured in terms of
peptide concentration required to induce leakage in 50% of the vesicles (EC50).205
Additionally, metallation creates a favorable local environment for the formation of
reactive oxygen species (ROS) that can chemically damage biological molecules including the
unsaturated fatty acid chains of the membrane lipids.206–208 Bacterial membranes mainly contain
saturated and monounsaturated phospholipids which do not easily undergo oxidative damage
under normal conditions. But some bacteria were discovered to integrate easily oxidized
exogenous polyunsaturated fatty acid in their membrane to escape antimicrobial agents through
changes in membrane structure, biofilm formation, and motility.114,209,210 The conditions that
enable membrane-disruptive interactions of metallopeptides with bacteria (e.g., labile copper
ions and ROS formation) are believed to be relevant in vivo as well.205 Oxidation of the
phospholipids by ROS can damage the bulk properties of the membrane (by e.g., increasing the
water content or passive permeability).207,211,212 The ROS-mediated oxidized phospholipids
(oxPLs) have a shortened acyl chain functionalized with aldehyde or hydroperoxyl groups.
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Moreover, few AMPs (e.g., indolicidin) were shown to exhibit increased interactions with
bilayers containing aldehyde-functionalized oxPLs suggesting that this type of oxPLs may
represent a novel molecular target of other AMPs including piscidin.206,213
Previously, MD simulations of P1 and P3 in binary lipid mixtures relevant to bacterial
membranes (e.g., POPC/POPG and POPE/POPG, where POPC: 1-palmitoyl-2-oleoyl-snglycero-3-phosphocholine, POPG: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol, and
POPE: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine, Figure 8A) have been carried
out to investigate (1) the effects of lipid composition on the surface-bound state of the peptides,
(2) the mechanism of membrane disruption, and (3) the structure and orientation of the peptides
in the bilayer.190,196,214,215 These studies have found that the two piscidins have distinct bilayer
orientations and insertion modalities (N- vs C-termini) which are dependent on the lipid
composition.190,196,214 Additionally, P1 was suggested to prefer surface defects over pore
formation as its mode of action.215 However, P1 and P3 bound to oxPLs-containing bilayers, or
metal-bound P1 and P3 in any lipid bilayers have not been characterized at the atomic level.
This study focuses on P1 and P3 and their capability to bind metal ions to enhance their
membrane disruptive effects. MD simulations were performed on both metallated and apo P1
and P3 in 3:1 POPC/POPG and 2.6:1:0.4 POPC/POPG/aldo-PC bilayers (where aldo-PC: 1palmitoyl-2-(9′-oxo-nonanoyl)-sn-glycero-3-phosphocholine, Figure 8). The first lipid mixture, a
well-accepted mimic of the bacterial membrane, was used to investigate how metallation alone
influences the bilayer structural parameters and the ability of piscidins to insert into the
membrane. The tertiary lipid mixture was utilized to study whether aldo-PC influences the
insertion depths and the topology that the piscidins adopt in the bilayer, as well as to determine
any aldo-PC-induced structural membrane changes. This study uses 10% aldo-PC because it has
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been suggested to be physiologically relevant under oxidative stress.216,217 In addition, studying
piscidins could be useful for understanding the mechanisms of other AMPs and metallopeptides
that share common features including the development of secondary structures upon membrane
binding. The information gathered from this study may help design novel therapeutics for
antibiotic-resistant infections.

Figure 8. (A) Structures of phospholipids of interest. Aldo-PC: 1-palmitoyl-2-(9′-oxo-nonanoyl)sn-glycero-3-phosphocholine, POPC: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine, POPG:
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol, and POPE: POPE: 1-palmitoyl-2-oleoyl-snglycero-3-phosphoethanolamine. (B) Representative input structure for the MD simulations of
piscidins in mixed lipid bilayers. Peptides are represented as green ribbons and licorices; the
phospholipids and water atoms are depicted as licorices and lines, respectively, colored as follows:
carbon – cyan, oxygen – red, nitrogen – blue, and hydrogen – light gray. Sodium ions are
represented as orange spheres.
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Computational Methods

MD simulations were performed on apo and Ni2+-bound P1 and P3 in 3:1 POPC/POPG
and 2.6:1:0.4 POPC/POPG/aldo-PC lipid bilayers with a ratio of one peptide per 40 lipids in
each leaflet of the bilayer (P/L = 1:40) using the AMBER18 software package218. Peptide-bilayer
systems were assembled using the Membrane Builder module within the CHARMM-GUI
interface.159,219 Initial peptide structures were generated as previously described for free
piscidins.196 Briefly, α-helical peptides with extended sidechains were generated. The center of
mass (COM) of the heavy backbone atoms of one peptide was aligned ~20 Å above the center of
the bilayer, while a second peptide was placed ~20 Å below the center of the bilayer. Each
peptide was rotated along its helical axis to assure that hydrophobic residues were facing the
bilayer interior. Each system contains a 16 Å water layer above each leaflet (~56 waters/lipid),
15-20 sodium ions, and chloride ions to neutralize the models and add a slight salt concentration.
Simulations were performed using the AMBER ff14SB protein force field136 and the Lipid17
force field.138 The force field for the oxidized lipid acyl chain containing an aldehyde functional
group was obtained using the Antechamber package220. The ATCUN-Ni2+ parameters were
generated using the python-based Metal Binding Protein Builder (MCPB) module139 in
AmberTools, which is a well-established tool for metal site parameterization. Peptides were
modeled with neutral histidine side chains according to previously reported pKa values.190
Solvent and counterions used the TIP3P water model221 with Joung and Cheatham monovalent
ions parameters222. MD simulations of apo P1 and P3 in POPC/POPG were performed for
comparison to the previous MD simulations in CHARMM.190,196,214 Simulations for peptide-free
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bilayers (3:1 POPC/POPG and 2.6:1:0.4 POPC/POPG/aldo-PC) were performed to estimate the
peptide-induced changes to the membrane.
Models were prepared for production simulations by initial minimization followed by
heating from 0 to 313K in four stages using the Langevin thermostat for a total of 150 ps.
Constant volume and weak restraints (force constants of 100 and 10 kcal mol-1 Å-2 on peptides
and lipids, respectively) were applied during the first stage (0 K to 100 K). The remainder of the
heating (from 100 K to 200 K (2), 200 K to 250 K (3), and 250 K to 313 K (4)) was conducted
under constant pressure using semi-anisotropic Berendsen regulation with a relaxation time of 2
ps. Production runs were performed at constant pressure (1 atm) and temperature (313 K) in a
monoclinic periodic box with zero surface tension using the PMEMD implementation223 of
AMBER 18. SHAKE constraints were applied to bonds to hydrogen atoms. Electrostatic
interactions were treated with the particle mesh Ewald method (cutoff = 10 Å). Since peptideinduced defect formation is on the microsecond time scale, the MD simulations were performed
for at least 2 μs with a 1 fs time step, which was preceded by a 100 ns equilibration run.
Analyses performed using the AmberTools CPPTRAJ routines157 and Python scripts were
averaged over duplicate simulations.
Area per lipid, volume per lipid, isothermal compressibility modulus, and bilayer
thickness were averaged over the 2.0 μs simulations (Tables 1 and 3). The area per lipid
parameter, defined as the average area each phospholipid occupies in the x- and y- plane
(containing the headgroups, Figure 8B), indicates whether the bilayer is in the correct phase (i.e.,
liquid crystalline or gel phase). Area per lipid (AL) can easily be computed from MD simulations
using the box dimensions according to eq. 10 where Lx and Ly are the x- and y- dimensions of
the simulation box, respectively, and mlipid is the number of lipids per leaflet.224
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Lx ×Ly

AL = m

(10)

lipid

Theoretical values were compared to the experimentally derived ones, but the experimental data
often depend on the technique used for the measurement and display a high degree of
uncertainty. Volume per lipid (VL) was calculated according to eq. 11, where Vbox is the volume
of the simulation box, nw is the number of water molecules, Vw is the volume of a water
molecule and nlipid is the total number of lipids in the bilayer.224 The volume of a TIP3P water
molecule was previously determined to be 30.53 Å3.225
VL =

Vbox −nw Vw
nlipid

(11)

The isothermal area expansion (compressibility) modulus, KA, was computed from the variation
in the area per lipid using eq. 12, where kB is Boltzmann’s constant, T is temperature, ⟨AL⟩ is the
average area per lipid and σA2 is the variance in the area per lipid.224
2kB T⟨AL ⟩

KA = n

lipid σA

2

(12)

KA values are indicative of the peptide-induced changes to the fluidity of the bilayer. Using the
Berendsen method for pressure coupling, we calculated a KA value for the peptide-free bilayer
that was within the experimentally obtained range. The average electron density profiles for all
five systems were calculated over 2 μs and decomposed into contributions from the following
groups: phosphate (PO4), methylenes (CH2), terminal methyls (CH3), and peptide backbone
(pepBB) using CPPTRAJ (Figure 9 and 17). The headgroup-to-headgroup (h(P-P)) and
hydrophobic (h(C2-C2), where C2 is from the sn-2 chain, Figure 8A) bilayer thicknesses were
computed using the peak-to-peak distance in the phosphate (purple) and methylene (gray)
decomposed electron density profiles, respectively. Deuterium order parameters (SCD) of the
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carbons in the acyl chains, were calculated according to eq. 13 for the bilayer alone and those
with piscidins.
1

SCD = 2 ⟨3cos2 θ − 1⟩

(13)

SCD reflects the chain mobility at a single carbon position and is a measure of the relative
orientation of C-D bonds about the z-axis. In equation 13, θ is the angle between the C-H (only
experimental measurements require deuterium, and H atoms have been used in the simulations)
vector and bilayer normal (z-axis), such that an SCD value of 1 infers a parallel position and
SCD=0 suggests total arbitrary motion.
The tilt (τ), and azimuthal rotational (ρ) angles were computed at 10 ns intervals relative
to a reference structure with φ/ψ angles of -61°/-45° and zero Euler angles. Peptide insertion
depths (z) were calculated as the distance between the center of mass (COM) of the peptide
heavy backbone atoms and the plane of the phosphorous atoms of the lipid headgroups. τ, ρ and
z were calculated separately for the N-terminal (residues 5-10) and C-terminal (residues 14-20)
ends because of the previously reported kinking at G13, the fraying of terminal residues196 and
the complexation of the N-terminus with Ni(II).

Results and Discussion

MD simulations of piscidins in POPC/POPG bilayers
MD simulations were performed on peptide-free, P1- and P3-bound 3:1 POPC/POPG/
bilayers for comparison with previous MD simulations carried out in CHARMM.214 Generally,
the results in this study are consistent with the CHARMM simulations.214 The area and volume
per lipid (AL and VL, respectively), as well as the compressibility modulus (KA) for the
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POPC/POPG bilayer alone, are in good agreement with the experimental values of a single
component bilayer suggesting that the system is well equilibrated in its liquid phase (Table 1).
The headgroup-to-headgroup (h(P-P)) and hydrophobic thicknesses (h(C2-C2)) computed from
the respective electron density profiles (Figure 9) are listed in Table 1. H(P-P) and h(C2-C2)
differ by ~10 Å. The absolute thickness values were shown to be different between the AMBER
and CHARMM force fields (i.e., h(P-P) ~37.5 Å and ~39.0 Å, respectively),226 but they both
follow similar trends (i.e., the difference between h(P-P) and h(C2-C2)).

Table 1. Average structural properties over two trials of the POPC/POPG bilayer system
simulations, where VL is volume per lipid, AL - area per lipid, KA - isothermal area
expansion modulus, h(P-P) – headgroup-to-headgroup thickness and h(C2-C2) –
hydrophobic thickness
POPC/POPG

Exp
MD

VL (Å3)

AL (Å2)

1256*227

64.3*,

1265§228

65.3§228

1206 ± 0

68.3*227

KA (mNm-1)
180-330¥229

h(P–P)
(Å)

h(C2–C2)
(Å)

37.0*227
36.0§228

254 ± 114

37.5 ± 0.2

27.4 ± 0.2

67.1 ± 0.4
+ P1

1290 ± 0

72.1 ± 0.5

208 ± 87

37.3 ± 0.4

27.4 ± 0.4

+ P3

1287 ± 1

71.8 ± 0.6

218 ± 120

37.2 ± 0.3

27.3 ± 0.4

+ P1-Ni2+

1290 ± 0

71.9 ± 0.4

202 ± 98

37.4 ± 0.3

27.5 ± 0.3

+ P3-Ni2+

1286 ± 0

71.4 ± 0.4

250 ± 98

37.5 ± 0.3

27.6 ± 0.3

The experimental value for pure POPC at (¥) 298 K, (*) 303 K and (§) 313 K
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Figure 9. Electron density profiles for P1 and P3 in POPC/POPG. Profiles are shown for the
phosphates (purple), peptides (blue), CH2 acyl chains (gray), and terminal CH3 (cyan). Electron
density profiles containing membrane and apo or metallated piscidin are in darker dashed or
solid lines, respectively, whereas the bilayer-only systems are in dashed black lines.

Backbone heavy-atom RMSDs for the first 20 residues of P1 and P3 with respect to the
first equilibrated structures suggest that P3 is slightly more flexible than P1 (RMSD = 0.98 Å vs
0.80 Å for P3 and P1, respectively). The orientation of each peptide, which maintained the αhelical structure throughout the simulations (Figure 10A, B), is described by the tilt (τ) and
azimuthal rotational angles (ρ, Figures 11 and A1, Table 2). The average orientation of the Nterminal end for apo piscidins is slightly toward the headgroups registering τ values of 95°,
whereas the C-terminal ends are parallel to the surface. In the experimental studies,196 ρ rather
than τ is the most relevant for distinguishing between P1 from P3. While P1 and P3 display
similar ρC values, the ρN of the latter is smaller (248° vs 261°), which means that the P3 Nterminal end does not distribute the hydrophobic and hydrophilic residues evenly in the
membrane. Similar orientations and kinked structures have been previously reported for P1 and
P3 in DMPC/DMPG and POPE/POPG bilayers (Δτ ~6-8° and Δρ ~15-20°).196 The peptide
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backbones for P1 and P3 are on average ~7-8 Å below the P atoms and just under the C2 atoms
of the lipids sn-2 acyl chain (Table 2). P1 inserts slightly deeper in the bilayer than P3 but both
experience similar differences in the zN and zC values (Δz ~ 0.1 Å) within the isoform.

Table 2. Tilt angles τ (°), azimuthal rotation angles ρ (°) and depths of insertion z (Å) for
the backbone atoms of N- (residues 5−10) and C- (residues 14−20) helical segments of each
peptide in POPC/POPG averaged over two trials. Insertion depth for the backbone atoms
of the full-length peptide (z1-22) is also reported
τN

τC

Δτ = (τN – τC)

P1

95 ± 1

88 ± 1

7.5 ± 1

P3

95 ± 1

89 ± 1

6.1 ± 0

P1-Ni2+

90 ± 1

83 ± 1

7.0 ± 1

P3-Ni2+

86 ± 2

82 ± 2

4.0 ± 1

ρN

ρC

Δρ = (ρN – ρC)

P1

261 ± 2

241 ± 1

19.5 ± 1

P3

248 ± 1

233 ± 2

15.3 ± 0

P1-Ni2+

251 ± 1

235 ± 1

16.0 ± 1

P3-Ni2+

237 ± 1

224 ± 1

12.7 ± 1

zN

zC

Δz = (zN – zC)

z1-22

P1

-8.2 ± 0.2

-8.3 ± 0.3

0.1 ± 0.2

-7.8 ± 0.3

P3

-7.4 ± 0.1

-7.5 ± 0.3

0.1 ± 0.2

-7.0 ± 0.2

P1-Ni2+

-9.1 ± 0.2

-8.0 ± 0.3

-1.2 ± 0.1

-8.2 ± 0.2

P3-Ni2+

-9.1 ± 0.4

-7.1 ± 0.2

-2.0 ± 0.5

-7.9 ± 0.2
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B

\

C

D

Figure 10. Snapshots from MD simulations of (A) P1, (B) P3, (C) P1:Ni2+, and (D) P3:Ni2+ in
POPC/POPG. Peptides are represented as yellow (P1 isoforms) or green (P3 isoforms) ribbons
and licorice. Phosphorous atoms are depicted as orange spheres while the rest of phospholipids
atoms except hydrogen are depicted as lines colored as follows: carbon – gray, oxygen – red, and
nitrogen – blue. Water molecules are represented as cyan points.
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The presence of piscidins in the bilayer reduces the height of CH2 and PO4 density peaks,
and asymmetrically widens the PO4 density peaks in both the current and previous simulations
(Figure 9).214 A decrease in the electron density for the bilayer components are expected when
other molecules are embedded in the bilayer. As these molecules move deeper into the bilayer,
they may pull in certain groups (i.e., PO4) causing an asymmetric widening of their density
peaks. Also, the insertion of apo peptides induces minimal P-P thinning and has little to no effect
on the C2-C2 thickness of the membrane (Table 1). In contrast, P1 and P3 reduced h(C2-C2) by
1.0 Å and 1.4 Å, respectively in the CHARMM simulations. The standard errors calculated for
these values (1.3-1.4 Å) suggest that the peptides cause large variation in the hydrophobic
thickness of the membrane including possible thickening. Additionally, the results of membranebound AMP simulations depend on the force field parameters suggesting that slightly different
results may be obtained and that researchers should take care in method selection.230 As noted
previously,214 an increase in AL and VL, and a reduction in KA are observed with the addition of
piscidins due to their interactions with the phospholipid headgroups and upper chain regions. A
similar inability of acyl chains to pack relatively tightly together (lower KA) was observed in the
MD simulations of fentanyl, an opioid analgesic, in a 1,2-dioleoyl-sn-glycero-phosphocholine
(DOPC) bilayer.231 The AL expansions agree with the results published by Perrin et al (VL data
has not been reported), but opposite KA changes in response to the two piscidins were reported
(P1 increases the KA and P3 decreases it).214 Altogether the membrane structural parameters for
the bilayer alone are in agreement with the experimental data, and the peptide-induced changes
noted in the current simulations are comparable with previous results.
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Figure 11. Distribution of tilt angles (τ), azimuthal rotation angles (ρ), and depths of insertion
sampled by the N- (blue) or C- (orange) terminal residues of P1 (left) or P3 (right) in
POPC/POPG during the 2-μs MD simulations. Curves for apo and metallated piscidins are
shown as dashed and solid lines, respectively.
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All-atom MD simulations of the metallated P1 and P3 in the 3:1 POPC/POPG bilayer
showed that both piscidins are dynamic in the membrane as suggested by the backbone heavyatom RMSDs for the first 20 residues of P1:Ni2+ and P3:Ni2+ (RMSD = 1.07 Å and 1.13 Å for
P1:Ni2+ and P3:Ni2+, respectively). The ATCUN residues have low RMSDs (0.19 Å and 0.22 Å
for P1:Ni2+and P3:Ni2+, respectively) similar to experimental values (M.L. Cotten, personal
communication). Examination of the MD trajectories confirmed that the metal-bound peptides
are embedded in the bilayer below the lipid phosphate plane and remained predominately αhelical with the hydrophilic residues oriented toward the water-bilayer interface, similar to the
apo peptides in the current and previous studies196. The sidechains of Arg and Lys were wellextended to preferentially interact with the negatively charged PG headgroups (Figure 10C, D).
The aromatic sidechains of the ATCUN motif and the adjacent residues have been
proposed to stabilize the Ni2+ ion through cation-π interactions and aid the insertion of the metalbound N-termini into the bilayer.232 Figure 12 shows the superposition of the ATCUN motif and
H4 residue for snapshots of P1:Ni2+ taken over 200 ns interval along the MD trajectory. While
the center of mass of F2 is positioned ~6.5 Å from the nickel center for 96% of the trajectories,
the aromatic groups of F1 and H4 make close contacts (~5.2 Å for 59% and ~4.2 Å for 94% of
frames, respectively) that are within the range expected for cation-π interactions.233,234 For 4% of
frames, the F1 phenyl group makes a much closer 4.0 Å contact. The longer distances for F2 and
F1 (~6.3 for 37% of frames) occur when their sidechains protrude into the lipid bilayer. The H4
imidazole faces the headgroup region of the bilayer and forms a cation-π interaction or fills a
fifth coordination site on Ni2+ through its δ-nitrogen. Similar interactions and average distances
were observed between Ni2+ and the sidechain of F1 and H4 in P3:Ni2+. Although these results
contrast with previous gas-phase DFT calculations that suggest a cation-π interaction with F2,232
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they confirm the potential for the metal center to be partially shielded by aromatic sidechains.
The role of F1 and not F2 in forming cation-π interactions with the Ni2+ ion is consistent with the
lack of change in the insertion depth of the N-terminal end (zN ~ 9.1 Å) when F2 (in P1:Ni2+) is
replaced by I2 (in P3:Ni2+).

Figure 12. Overlays of the ATCUN residues and H4 for the P1:Ni2+ structures in POPC/POPG
taken from the MD simulations at intervals of 200 ns (0:20:209). The structures from the
beginning of the trajectory are colored red, the middle are white, and the end are blue. H4 residue
is taken at (A) t = 1100 ns, (B) t = 1700 ns, (C) t = 2100 ns.

The dynamic nature of membrane-bound piscidin is reflected in the distribution of τ and
ρ which do not change significantly in the presence of the Ni2+ ion (Figure 11). The overall loss
of charge and the shielding of the metal by coordination and by hydrophobic sidechains make it
less attracted to the negatively charged phosphate groups. As a result, the N-terminal end no
longer points towards the phosphate groups and is now parallel to the surface for P1:Ni2+ and
slightly canted toward the bilayer center (τ = 86°) in P3-Ni2+ (Table 2). The orientation of the C-
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terminal ends, which were parallel to the surface for the apo piscidins, are tilted toward the
bilayer core in the metallated peptides. This trend could be attributed to the need to maintain the
kinked structures (Δτ ~ 4-8°) which is more pronounced in P1. The MD τ values follow a similar
trend to the experimental results (M.L. Cotten, personal communication): Ni2+-bound peptides
are tilted more towards the bilayer center than the apo peptides. P1:Ni2+ and P3:Ni2+ adopt more
distinct ρ angles than the apo peptides (Table 2). Values of ~260° and ~235° for the apo peptide
ρN (N-terminal residues) and ρC (C-terminal residues), respectively, assure an even distribution
of the hydrophobic residues at the hydrophobic core of the lipids and the hydrophilic residues at
the water-bilayer interface (Figure A1).196 ρN values for P1 and P3 decrease by 10° and 11°,
respectively, upon metallation. These changes allow the F1 and F2/I2 ATCUN residues to be
better positioned in the lipid hydrophobic core and for H3 to be better placed at the water-bilayer
interface. In contrast, the reduction in the ρC values allows the C-terminus hydrophobic and
hydrophilic residues of P1:Ni2+ to be more evenly distributed in the bilayer than ones of P3:Ni2+
(Figure A1). Thus, the metallation has a different effect on the C-terminal end orientation in the
membrane of these two isoforms. The Δρ (ρN - ρC) is reduced by only ~3.5° upon metal-binding
for the following trend in Δρ: P1 > P1:Ni2+ ≈ P3 > P3:Ni2+. Therefore, the helical rotations on
each side of the kink at G13 (the end of the G(X)4G motif) is dependent on both the sequence
and the metallation state. The distinct rotation of the two ends of piscidins is required to
maximize their hydrophobic interactions with the bilayer.
Generally, the peptide backbones for metallated piscidins are found at similar positions in
the membrane compared to the apo peptides: ~7-8 Å below P atoms and just under the C2 atoms
of the lipids sn-2 acyl chain (Table 2). Charge neutralization and metal-binding in the formation
of the ATCUN complex influence the insertion of N-termini in the bilayer to a greater extent
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than the C-termini. The distribution of insertion depths for the N-termini (zN) cover a relatively
small range, and the values are downshifted when metallated, especially for P3-Ni2+ (Figure 11).
In contrast, the C-termini depths (zC) have wider distributions and are indistinguishable between
the apo and holo state of each isoform. Metallation deepens the N-terminal end in the membrane
by ~0.9 Å for P1:Ni2+ vs. apo P1 and ~1.7 Å for P3:Ni2+ vs. apo P3, with both metallated
isoforms sharing a zN of ~9.1 Å (Table 2). The enhanced insertion of P1:Ni2+ and P3:Ni2+ may
contribute to their higher toxicity toward planktonic bacteria when compared to the apo
peptides.235 To compensate for the increase in the magnitude of zN, the C-terminal ends of the
metallated peptides remain somewhat closer to the headgroups than their apo counterparts
resulting in a greater |∆𝑧| (|zN - zC|, 1-2 Å vs 0.1 Å).
The insertion of P1:Ni2+ causes a negligible P-P thinning, while P3:Ni2+ does not modify
the bilayer thickness (Table 1). At the same time, the C2-C2 distance slightly increases upon the
insertion of the metallated peptides. The decomposed electron density profiles with contributions
from the peptide backbone are asymmetrical suggesting an uneven distribution of the peptides in
each leaflet (Figure 9). The mean distance of piscidin from the bilayer center increases in the
following order P1:Ni2+ < P3:Ni2+ < P1 < P3 with P1: Ni2+ displaying a density maximum at
~9.9 Å. As such, metallation promotes a deeper peptide insertion into the bilayer which causes
the membrane to thicken by extending the acyl chains. Similar bilayer behavior is also observed
upon cholesterol incorporation into the membrane.236,237 Metallation yields a smaller increase in
AL which stipulates a less dynamic diffusion of metal-bound peptides into the bilayer. In terms
of KA, P1:Ni2+ displays the greatest decrease suggesting that metallated P1 increases the fluidity
of the membrane the most. Surprisingly, P3:Ni2+ shows an insignificant change in KA compared
with the bilayer alone, but the apo systems do show a decrease. The insignificant change in KA
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suggests a lack of conformational changes in the headgroup region, which would restrict the
fluidity and may be caused by metallation-promoted fast diffusion of P3:Ni2+ through the
headgroups.

peptide+bilayer

Figure 13. Average SCD

bilayer

/SCD

for the (top) sn-1 and (bottom) sn-2 lipid acyl chains in

the presence of P1 (yellow), P3 (orange), P1-Ni2+ (green), and P3-Ni2+ (blue).

Deuterium order parameters (SCD) of the carbons in the acyl chains (sn-1 and sn-2
positions of the glycerol core) indicate how straight (larger values) or kinked (smaller values) a
lipid tail is, and usually are affected by peptide insertion. The ratio between SCD of the systems
with piscidin and that of bilayer alone is plotted separately for sn-1 (saturated) and sn-2
(unsaturated) chains in Figure 13. A value above 1 for the SCD ratio indicates an increase in order
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in the presence of the piscidin peptides. As previously reported,214 sn-1 and sn-2 chains do not
share the same ratio, an indication of different responses to the peptide. In the presence of
peptides, the sn-1 chains exhibit a slight increase in the order of carbons near the headgroups and
a continuous reduction with the lower carbons. There is no discrimination for a particular
isoform (P1 or P3) or state (apo or Ni2+-bound) in the SCD values for these tails. The disorder of
the sp3 carbon in the saturated chain slightly increases in the presence of apo P3 but does not
change with the other peptides. The sn-2 chain unexpectedly displays a greater packing order for
all carbons except C10, the 2nd sp2 carbon, (indicative of kinked tails at this position) when
piscidin, especially P1-Ni2+, is present. P3 being the least inserted into the bilayer induces little
change in SCD of the carbons after the double bond (C9-C10, sn-2 chain) and only a modest
decrease in the case of C10. These smaller values for C10 could account for the decreased KA in
the peptide-containing systems where P1-Ni+ induces the highest reduction.

MD simulations of piscidins in POPC/POPG/aldo-PC bilayers
MD simulations were performed on POPC/POPG/aldo-PC bilayer alone for comparison
with the POPC/POPG bilayer. Both peptide-free membranes are in the fluid phase and well
equilibrated since the calculated AL for the POPC/POPG and POPC/POPG/aldo-PC bilayer alone
agree well with the experimental AL values for the pure POPC bilayer (Tables 1 and 3). While
almost identical AL values were obtained for the two membranes, smaller VL (1183 vs 1206 Å3)
and thicknesses (thinning by ~1 Å for both h(P-P) and h(C2-C2)) were calculated for the aldoPC-containing bilayer consistent with the shortened acyl chain of aldo-PC. The lower KA for the
POPC/POPG/ aldo-PC versus POPC/POPG bilayer (243 ± 88 vs 254 ± 114) suggests that the
presence of 10% aldo-PC increases the fluidity of the membrane and reduces the interactions
between the headgroup constituents (Figure 14). This observation is further supported by the SCD
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parameters which indicate that the disorder of the lipid acyl chains in the presence of aldo-PC
steadily increases starting with the first sp2 carbon (Figure 15C). Interestingly, C10 of the sn-2
chain is the only carbon where the lipid tails experience a straighter, more ordered position in the
aldo-PC-containing bilayer, in contrast to the piscidin-bound POPC/POPG membranes (Figure
9). The carbonyl functionalized chains often reorient to reach the headgroup region contributing
to the destabilization of the bilayer (Figure 15B). Similar interfacial conformations were
previously reported from the simulation of 25% aldo-PC in POPC.213 Thus, a more fluid (liquidlike) membrane (lower KA and SCD), which contains more kinked lipid tails (smaller SCD) in the
presence of aldo-PC is consistent with the ability of oxPLs to disrupt membrane bulk proprieties
and exhibit enhanced permeabilization.207,211,212
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Figure 14. Average hydrogen bonds per frame between PC and PG headgroups in (A)
POPC/POPG and (B) POPC/POPG/aldo-PC bilayer.
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Table 3. Average structural properties over two trials of the POPC/POPG/aldo-PC bilayer
system simulations, where VL is volume per lipid, AL - area per lipid, KA - isothermal area
expansion modulus, h(P-P) – headgroup-to-headgroup thickness and h(C2-C2) –
hydrophobic thickness
POPC/POPG/
aldo-PC

h(C2–C2)
(Å)

AL (Å2)

1256*227

64.3*,65.3§228

1265§228

68.3*227

MD

1183 ± 0

67.7 ± 0.6

243 ± 88

36.4 ± 0.2

26.3 ± 0.3

+ P1

1267 ± 0

72.5 ± 0.5

185 ± 81

36.3 ± 0.3

26.3 ± 0.5

+ P3

1264 ± 0

72.1 ± 0.5

198 ± 95

36.3 ± 0.4

26.4 ± 0.5

+ P1-Ni2+

1267 ± 0

72.2 ± 0.4

222 ± 93

36.5 ± 0.3

26.6 ± 0.3

+ P3-Ni2+

1264 ± 0

71.9 ± 0.5

212 ± 86

36.5 ± 0.3

26.5 ± 0.4

Exp

KA (mNm-1)

h(P–P)
(Å)

VL (Å3)

180-330*229

37.0*227
36.0§228

The experimental value for pure POPC at (*) 303K and (§) 313K
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Figure 15. Comparison between POPC/POPG and POPC/POPG/aldo-PC bilayer alone.
Snapshots from MD simulations of (A) POPC/POPG and (B) POPC/POPG/aldo-PC. Aldo sn-2
acyl chains are represented as licorice and the carbonyl group as spheres. Phosphorous atoms are
depicted as orange spheres while the rest of the phospholipid atoms except hydrogens are
depicted as lines colored as follows: carbon – gray, oxygen – red, and nitrogen – blue. Water
molecules are represented as cyan points. (C) Average SPOPC/POPG/aldo-PC
/SPOPC/POPG
for the sn-1
CD
CD
and sn-2 lipid acyl chains.

All-atom MD simulations for apo and metallated P1 and P3 in 2.6:1:0.4
POPC/POPG/aldo-PC bilayer were performed to study the membrane-bound piscidins in the
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presence of oxPLs. As previously observed, AL increases upon the addition of piscidin peptides
to the bilayer with a slightly more pronounced expansion for the P1 isoform (Table 3). A greater
change in AL is associated with a more dynamic diffusion of the peptide molecules into the
bilayer. Since the AL increase is lower in the presence of metal-bound peptides, one may assume
that the net loss of one positive charge upon metallation leads to reduced electrostatic
interactions with the headgroup regions, hence a less dynamic diffusion. The calculated VL share
a similar trend with the AL, but contrary to the latter, are slightly smaller when compared with
the POPC/POPG bilayers due to the shortened functionalized sn-2 chain (Table 1 and 3). Upon
insertion, the peptides induce a disruption within the phospholipid chain packing that promotes
membrane fluidity as shown by the ~9-24% drop in KA (Table 3). The apo peptides have lower
KA than the metallated piscidins with P1:Ni2+ displaying the lowest decrease in KA among the
tested peptides, in contrast to its performance in the POPC/POPG bilayer. As in the case of
P3:Ni2+ in POPC/POPG, the smaller KA change induced by Ni2+-bound piscidins may be the
result of faster peptide diffusion into the membrane in agreement with the calculated AL values.
This fast diffusion in conditions of aldo-PC and Ni2+ ions should yield minimum disruption of
the interactions (e.g., hydrogen bonding) between the lipid headgroup constituents. Figure 14
shows that while the average number of hydrogen bonds generally lowers in the presence of
piscidin, P1:Ni2+ (and P3:Ni2+ in POPC/POPG) induced only a slight decrease in hydrogen
bonding.
The ratio of SCD for the piscidin-containing systems and bilayer alone is plotted
separately for sn-1, sn-2, and sn-2 (aldo-PC) in Figure 16. The trends in the SCD ratios of the sn-1
and sn-2 chains, which generally react differently to the peptide insertion, are not significantly
influenced by the presence of aldo-PC. The sn-2 chains (except for the C10 carbon) also have a
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greater packing order than the sn-1 ones in the presence of piscidins. Here, apo P3 is positioned
farthest from the bilayer center and induces the least amount of change to the order of the sp2
carbon and the subsequent carbons; but it is not as distinguishable from the other peptides as in
the POPC/POPG membrane. Generally, sn-2 carbons following C10 are less kinked (higher SCD)
in the presence of Ni2+-bound piscidins which agrees with the smaller KA change in these
systems. The aldo-functionalized sn-2 tails have a unique behavior in the presence of the
peptides. They occasionally reorient to expose the carbonyl groups to the water phase in addition
to positioning at the phosphate interface (Figure 17B and C). Such a reversal is expected to
influence membrane structure more strongly. The large increase in packing order for the first
three (C2-C3-C4) carbons, hence straighter lipid chains, is interrupted at C5 when a sharp drop
places the rest of the carbons in a disordered state (more kinked tails).
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peptide+bilayer

Figure 16. Average SCD
OL lipid

(blue).

bilayer

/SCD

for the (top) sn-1, (middle) sn-2, and (bottom) sn-2aldo-

acyl chains in the presence of P1 (yellow), P3 (orange), P1-Ni2+ (green) and P3-Ni2+
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Figure 17. Snapshots from MD simulations of (A) P1, (B) P3, (C) P1:Ni2+ and (D) P3:Ni2+ in
POPC/POPG/aldo-PC. Peptides are represented as yellow (P1 isoforms) or green (P3 isoforms)
ribbons and licorice. Ni2+ ions and phosphorous atoms are depicted as green and orange spheres,
respectively, while the rest of the phospholipid atoms except for hydrogen are depicted as lines
colored as follows: carbon – gray, oxygen – red, and nitrogen – blue. Aldo sn-2 acyl chains are
represented as licorice, and water molecules as cyan points.
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The incorporation of oxPLs into the bilayers does not significantly affect the electron
density profiles as they share features with POPC/POPG systems (Figures 9 and 18). Similar
changes are observed upon piscidin insertion either in the presence or absence of aldo-PC except
for a larger decrease in the PO4 density peak in the POPC/POPG/aldo-PC bilayers. The
headgroup-to-headgroup bilayer thickness (h(P-P)), calculated from the phosphate electron
density profiles, is ~10 Å greater than the hydrophobic one (h(C2-C2)) (Table 3). The same
difference was observed for POPC/POPG membranes in this study and previously reported by
Perrin et al214. Apo piscidins slightly reduce the P-P thickness whereas the Ni2+-bound ones have
an opposite effect (Table 3). At the same time, the C2-C2 thickness of the POPC/POPG/aldo-PC
bilayer widens in the presence of all peptides except apo P1. Generally, an increase in the bilayer
(hydrophobic) thickness may be caused by the extension of acyl chains followed by an increase
in SCD. The maximum density of P1:Ni2+ peptide is on average ~9.3 Å (vs. ~9.9 Å in
POPC/POPG) which places it closest to the bilayer center, followed by P3:Ni2+ then P1 and P3.
As noted for the POPC/POPG systems, peptide position in the membrane deepens with
metallation which promotes acyl chain extensions and membrane thickening.
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Figure 18. Electron density profiles for P1 and P3 in POPC/POPG/aldo-PC. Profiles are shown
for the phosphates (purple), peptides (blue), CH2 acyl chains (gray), and terminal CH3 (cyan).
Electron density profiles containing membrane and apo or metallated piscidin are in dashed or
solid lines, respectively, whereas the systems with only the membrane are in dashed black lines.

The piscidin peptides do not change their flexibility in the presence of aldo-PC as
indicated by the analogous backbone heavy-atom root-mean square deviations (RMSDs) for the
first 20 residues (RMSD = 0.75/0.78 Å and 0.83/0.89 Å for P1/P1:Ni2+ and P3/P3:Ni2+,
respectively). The ATCUN residues also maintain low RMSD values in POPC/POPG/aldo-PC
(0.20 Å and 0.22 Å for P1:Ni2+and P3:Ni2+, respectively). Like in the case of the POPC/POPG
systems, both metallated and apo α-helical peptides diffused below the phosphorus plane of the
aldo-PC-containing bilayer orienting the hydrophilic residues toward the water-bilayer interface
(Figures 10 and 17). The cationic sidechains are well-extended and interact preferentially with
the anionic PG headgroups towards the end of the simulation. As in the POPC/POPG bilayer, the
apo piscidins orient the N-terminal end on average toward the headgroups (τ = 95°/93) with
azimuthal rotation angle (ρ) values of 259° and 249° for P1 and P3, respectively (Table 4).
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Table 4. Tilt angles τ (°), azimuthal rotation angles ρ (°) and depths of insertion z (Å) for
the backbone atoms of N- (residues 5−10) and C- (residues 14−20) helical segments of each
peptide in POPC/POPG/aldo-PC averaged over two trials. Insertion depth for the
backbone atoms of the full-length peptide (z1-22) is also reported
τN

τC

Δτ = (τN – τC)

P1

95 ± 1

88 ± 1

7.6 ± 1

P3

93 ± 0

89 ± 1

4.5 ± 1

P1-Ni2+

90 ± 1

83 ± 1

6.6 ± 1

P3-Ni2+

85 ± 1

83 ± 1

2.1 ± 1

ρN

ρC

Δρ = (ρN – ρC)

P1

259 ± 2

240 ± 2

19.0 ± 1

P3

249 ± 3

228 ± 4

21.0 ± 2

P1-Ni2+

251 ± 1

234 ± 2

16.3 ± 1

P3-Ni2+

232 ± 4

216 ± 2

16.0 ± 6

zN

zC

Δz = (zN – zC)

z1-22

P1

-8.1 ± 0.2

-8.2 ± 0.4

0.2 ± 0.2

-7.7 ± 0.2

P3

-7.6 ± 0.1

-7.6 ± 0.1

0.0 ± 0.0

-7.2 ± 0.1

P1-Ni2+

-9.2 ± 0.3

-8.0 ± 0.3

-1.2 ± 0.1

-8.4 ± 0.3

P3-Ni2+

-8.7 ± 0.2

-6.9 ± 0.2

-1.8 ± 0.2

-7.6 ± 0.1

Metallation decreases the charge of the ATCUN motif by one but does not alter the
dynamics of the membrane-bound piscidins (Figure 19). In the presence of aldo-PC, the
orientation of the N-terminal end remains parallel to the surface for P1:Ni2+ and slightly toward
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the bilayer core (τN = 85°) for P3:Ni2+ (Table 4). The kinked peptides at Gly13 tilt the C-terminal
ends toward the bilayer center for the Ni2+-bound piscidins or position it parallel to the surface
for the apo piscidins, as observed in the absence of aldo-PC or when bound to membranes of
different composition (P1/P3 in DMPC/DMPG and POPE/POPG bilayers)196. In terms of the
azimuthal rotation angles, the P1 values are affected only by metal binding as P1:Ni2+ experience
similar ρ in both lipid mixtures, while the P3 ρ values respond to the addition of metal ion and
lipid oxidation since ρN and ρC of P3:Ni2+ decrease by 5° and 8°, respectively, and sample a
broader range in POPC/POPG/aldo-PC (Tables 2 and 4, and Figure 19). This ρC reduction
aggravates the uneven distribution of the C-terminal hydrophobic and hydrophilic residues in the
bilayer. P3 is the only isoform that slightly changes its Δρ values in the presence of aldo-PC
(5.7° and 3.3° increases for the apo and Ni2+-bound piscidin, respectively) and the following Δρ
trend is recorded for the studied peptides: P3 > P1 > P1-Ni2+ ≈ P3-Ni2+. Increased structural
changes of piscidins (i.e., P3) may be due to more interactions with the aldo-PC-containing
bilayer which could suggest that P3 is more efficient than P1 at permeabilizing bacterial
membranes in the presence of aldo-PC.
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Figure 19. Distribution of tilt angles, azimuthal rotation angles, and depths of insertion sampled
by the N- (blue) or C- (orange) terminal residues of P1 (left) or P3 (right) in POPC/POPG/aldoPC during the 2-μs MD simulations. Curves for apo and metallated piscidins are shown as
dashed and solid lines, respectively.
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The average insertion depths (z) of piscidin relative to the P atoms of all the headgroups
from the same leaflet as the peptide are listed in Table 4 and their distribution is plotted in Figure
19. The peptide backbones are located at similar depths in the POPC/POPG/aldo-PC bilayer as to
those in the aldo-PC-free membrane (~7-8 Å below P atoms and just under the C2 atom of the
lipids sn-2 acyl chains). As a result, the depth of insertion of the N- (zN) and C-terminal (zC) end
for both apo and Ni2+-bound piscidins have similar values and distributions in the presence of
aldo-PC as in its absence. The two peptide isoforms share alike distribution plots for the insertion
depths where the N-termini sample a relatively narrow zN range compared with the C-termini
and downshift upon metallation. P1 inserts its terminal ends into the aldo-PC-containing
membrane deeper (by ~0.5 Å) than P3, consistent with their activity in POPC/POPG bilayer
reported in this study and previously by Perrin et al214 (Table 4). Metallation advances the
diffusion of the N-terminal ends by ~1.1 Å deeper into the membrane such that the zN of P1:Ni2+
becomes distinguishable from P3:Ni2+ in the presence of oxPLs (zN ~9.2 Å vs. 8.7 Å).
Meanwhile, the peptides C-terminal end, particularly of P3:Ni2+, inserts less than their apo
counterparts and continue to yield larger |Δz|. Thus, the formation of the ATCUN complex
influences the orientation of the N-terminal end in the bilayer to a greater extent than the Cterminal end, since the latter one is not chemically modified.
31

P NMR studies have shown that the PG headgroup region responds more strongly to

P1:Ni2+, but not P3:Ni2+, in the presence of aldo-PC and at 1:20 peptide-to-lipid ratio.205 The
interactions between piscidin and headgroups (PC-peptide and PG-peptide) were assessed
through hydrogen bond analysis. The absolute values for these interactions do not necessarily
reflect the peptide preference for a specific headgroup region since neither the number of each
headgroup (60 PC vs 20 PG) in the bilayer nor the number of donor/acceptor sites per molecule
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(9 vs 12 in PC and PG, respectively) is equal. Nonetheless, this analysis can offer insights into
how aldo-PC changes the interactions patterns of piscidin with the lipid headgroups. As seen in
Figure 20, the average number of PG-peptide hydrogen bonding interactions slightly increases
for P1:Ni2+, but not for P3:Ni2+ in the presence of aldo-PC, in perfect agreement with the
experimental data205. In the case of apo piscidin, P1 increases its hydrogen bonding with the PC
headgroups, and reduces those with PG, whereas P3 follows an opposite trend. Altogether, these
results suggest that in the presence of oxPLs, P1:Ni2+ may interact more readily with the anionic
PG headgroups, which correlates well with the enhanced membrane activity of the peptide on the
POPC/POPG/aldo-PC lipid mixture.205

Figure 20. Average hydrogen bonds per frame between piscidin and lipid headgroup
constituents in (A) POPC/POPG and (B) POPC/POPG/aldo-PC bilayer.
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Conclusions

Piscidins are a promising template for novel antimicrobial and antiviral therapeutics.
Their activity is enhanced in vitro by the formation of the ATCUN-Ni2+ complex and the
presence of oxidized lipid species. All-atom MD simulations examined the effect of piscidin
metallation and oxidized lipid incorporation on the structural properties of the bacterial
membrane and its interactions with the peptides. Apo and metallated P1 and P3 bound to binary
(POPC/POPG) or tertiary (POPC/POPG/aldo-PC) lipid mixtures were used as models for this
investigation. Piscidins are shown to be flexible in the membrane and insert at distinct depths
that depend on the particular isoform (P1 vs P3) and state (free or Ni2+-bound). The magnitude of
the insertion depths has been proposed to be indicative of the membrane activity of piscidins.
Apo P1 tends to insert deeper than P3 with no preference for a particular terminal end, while
both Ni2+-bound piscidins become more tilted and insert their N-terminal ends deeper in the
bilayer. Thus, metallation is expected to enhance the membrane activity of these peptides.
Piscidin insertion induces structural changes to the bilayer that could precede complete
membrane disruption and bacteria death. Upon peptide insertion, the bilayer becomes more fluid
(“liquid-like”) and expands in all directions. Metallated piscidins induce a smaller expansion
possible due to faster diffusion into the bilayer as a result of the net loss of a positive charge. The
less cationic metal-bound peptides could more readily overcome the electrostatic interactions
with the anionic PG headgroups to successfully insert into the bilayer. In the presence of aldo-PC
whose functionalized chains reorients towards the aqueous phase, the number of hydrogen bonds
between the headgroup constituents is reduced. Such observations support the idea of oxPLs
incorporation disrupting the bulk properties of the membrane. The peptides do not significantly
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modify their orientations and insertion depths in the presence of oxPLs; but computational
evidence for P1:Ni2+ prompter association with the bacterial anionic headgroups is shown, which
is in agreement with NMR data. Altogether, these results suggest a potential mechanism for the
enhanced activity of metallated peptides in the presence of oxPLs considering that a deeper
insertion and a preferential association with anionic headgroups may promote the disruption of
the bacterial membrane.
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CHAPTER III
MOLECULAR DYNAMICS SIMULATIONS OF REDUCED AND OXIDIZED TFIIIA ZINC
FINGERS FREE AND INTERACTING WITH 5S RNAa

Introduction

Zinc fingers (ZF), one of the largest classes of proteins, are an important subset of zincbinding proteins that carry out a broad range of cellular functions including transcription, signal
transduction, DNA repair, cell proliferation, differentiation, apoptosis, and tumorigenesis.238–
241,94,242–244

ZFs are grouped into three classes based on the combination of Cys and His residues

in the tetrahedral coordination sphere of Zn2+: Cys4, Cys2HisCys, or Cys2His2.93,94 The Zn2+ ion
is required for proper folding of these domains. The Zn2+-bound Cys2His2-type folds into a ββα
structure and was initially discovered as a sequence-specific DNA binding motif in transcription
factor IIIA (TFIIIA) of Xenopus laevis.245 Cys2His2-type ZFs mediate various protein-protein
and/or protein-nucleic acids interactions.246 Examples include the IKAROS family,247 Kruppel
like factors (KLF),248 specificity proteins (SP)249 and Zif268/Egr-1.250 TFIIIA recognizes and
binds nucleic acids through nine ZF domains.251 In addition to two clusters of three-ZFs that bind
the 5S DNA, the three or four middle ZFs are selective for 5S RNA binding.
Reactive oxygen species, reducible sulfur/selenium compounds, and other cellular
oxidants inhibit ZnS proteins through oxidization of the Cys thiolates.252–257,96,101,258,100,95,259 The

a

Reprinted with permission from Dreab, A; Bayse, C. A. Molecular Dynamics Simulations of
Reduced and Oxidized TFIIIA Zinc Fingers Free and Interacting with 5S RNA. J. Chem. Inf.
Model. 2022, 62, 903-913. Copyright 2022 American Chemical Society. The manuscript can be
found online at https://doi.org/10.1021/acs.jcim.1c01272.
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disulfide bond, the major oxidation product at pH 7.0, cannot effectively coordinate Zn2+ which
leads to the unraveling of the tertiary structure required for nucleic acid recognition and
binding.241,257,95,259,260 As a result, Zn2+ release is associated with disruption of gene expression
and DNA repair, which can prevent tumor growth.259,261 Inhibition of ZF proteins involved in the
survival and proliferation of cancer cells, such as histone lysine methyltransferases G9a and
GLP,115,262 breast cancer-associated protein 2 (BCA2),263 or transcriptional coactivators
p300/CBP116,117 is a promising strategy for cancer treatment. The transcription factor ZNF143
with seven Cys2His2-type ZFs is overexpressed in many tumors and promotes cisplatin
resistance.264–266 Targeted oxidation of ZNF143 could inhibit DNA binding and serve as a
potential therapeutic. ZFs oxidation is also a potential mechanism for treating viral infections.
For example, disulfiram and ebselen were shown to eject Zn2+ from the multiprotein SARSCoV2 replication and transcription complex and inhibit replication when combined with
remdesivir.98,99
TFIIIA binds to 5S DNA and 5S RNA via distinct molecular mechanisms.267 5S DNA
binding by TFIIIA has been modeled computationally, but only one short simulation of ZF456 of
TFIIIA - 5S RNA has been reported in the literature.268–272 TFIIIA promotes the expression of
the 5S RNA gene during oogenesis acting as a positive transcription factor.273–276 TFIIIA also
serves as a storage particle when bound to 5S RNA in the cytoplasm forming the 7S
ribonucleoprotein (7S RNP).277,278 Studies suggest that 7S RNP formation depends on the
structure and conformation of 5S RNA and many weak protein–RNA sequence-specific
interactions.279–281 TFIIIIA binding to RNA is entropically and enthalpically favored (Kd  1 nm)
through the formation of approximately five salt bridges between lysine residues and the RNA
nucleotide phosphate backbone.282 Key TFIIIA residues for 5S RNA recognition and the
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minimum RNA regions that sustain the binding have been identified by protein mutagenesis and
RNA deletion analysis.278,283–286

Figure 21. NMR structure and sequence of the ZF456-55mer 5S RNA complex. (A) NMR
structure of the ZF456-5S RNA complex (PDB: 2HGH, conformer 2)287. The three zinc fingers
are depicted as cartoons and colored in cyan (ZF4), blue (ZF5), and orange (ZF6). The gray
spheres represent the Zn2+ ions. (B) Cartoon representation of ZF456 peptide. (C) Sequence
and corresponding secondary structure of ZF456 with the conserved Zn2+ binding Cys and His
residues shown in yellow and blue, respectively.

ZF456 represents the minimal polypeptide required for high-affinity binding to 5S
RNA.283,288 These ZFs bind similarly to the central core region of 5S RNA (loop B/helix II/loop
A/helix V/region E, Figure 21A) either in the full-length TFIIIA molecule or truncated
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peptide.278,283,288 Interactions between ZF456 and loop A, in particular, are required for proper
RNA recognition by ZF5 and ZF6.289 In ZF4-7, simultaneous alanine substitutions of α-helix
residues at positions -1, +2, +3, and +6 in ZF4 and ZF6 (the N-terminal residue in the α-helix is
at position +1, Figure 21C) reduced the affinity for 5S RNA by 77-fold and 43-fold,
respectively.286 Single mutations at position -1 (e.g., K118A in ZF4-7 and T176I in Zn1-7) lead
to more than 36.5-fold reductions in RNA binding.283,286 Alanine replacement of Trp177
(W177A) resulted in decreased 5S RNA binding in the full-length protein and complete loss of
binding in the ZF456 peptide.278 However, the W177F mutant retained the affinity for 5S RNA
in both ZF456 and full-length TFIIIA278 suggesting that Trp177 is important for RNA
recognition through π-stacking with A6.253,278,290 Substitution of the Thr176-Trp177-Thr178
(TWT) motif with RSD from Wilms tumor suppressor protein WT1 reduced the affinity for 5S
RNA by ~11-fold.285
NMR and molecular dynamics (MD) studies of ZF456 - 5S RNA complexes have
provided additional context for the biochemical, mutagenesis, and crystallographic
studies.268,278,283–285,287–290 For example, hydrogen bonding between the 2՛-hydroxyl of G26
hydrogen and Tyr105 could be obstructed by an Mg2+ in the crystal structure as an artifact of the
buffer solution.287,290 Additionally, ZF5 appears to be a nonspecific spacer element dependent
upon the base-specific contacts made by its neighboring ZFs with RNA despite the enhancement
of RNA binding by the interactions of its basic residues with the phosphate backbone.287,290
Nanosecond scale molecular dynamics (MD) simulations of a ZF456 – 61mer 5S RNA, starting
from its crystal structure (PDB: 1UN6)28 showed that interdomain motions observed upon RNA
binding involved burial or exposure of key residues for DNA or RNA binding, respectively
(Leu148 and Trp177, respectively).268
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These experimental and computational studies have provided a picture for interactions of
reduced ZFs with RNA, but neither the effect of Cys oxidation on ZF proteins nor the interaction
of oxidized ZFs with nucleic acids has been examined at the atomistic level. Here, multimicrosecond MD simulations were performed on ZF456 bound to its cognate 5S RNA and free
ZF456 in both reduced and oxidized forms to determine how oxidation of the ZFs affects the
conformation of the free and RNA-bound protein. Since structural transitions in biomolecules
can require an extended time scale,291 MD simulations were performed for up to 30 μs;
conformation changes that occur on longer timescales may not be observed. Disulfide bond
formation is shown to induce significant conformation changes in the free protein that would
inhibit RNA binding. In the oxidized ZF456-RNA complex, major hydrogen bonds important to
recognition are lost which may lead to dissociation of the oxidized ZFs over longer timescales.

Computational Methods

The initial protein and protein-RNA models were obtained from the solution NMR
structure of TFIIIA ZF456 bound to 5S rRNA 55-mer (PDB: 2HGH; residues 104-190,
conformer 2).287 The H++ server292 was used to inform the assignment of His protonation states
in the presence and absence of RNA (protonated His108 and His119 when bound to RNA,
unprotonated otherwise, and protonated His139 in both cases). Since NMR data suggests that
His119 is protonated upon RNA binding,287 two sets of protonation states were considered for
His outside the Zn2+ coordinate sphere (Table 5) to account for the H++ pKa-based prediction
and experimental observations. For oxidized ZF models, Zn2+ was removed; the hydrogen on the
δ-nitrogen of Zn-binding His residues (HID) was relocated to the ε-nitrogen (HIE); and a
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disulfide bond was created between the Zn-binding Cys residues (CYX). MD simulations were
performed using the PMEMD GPU implementation in AMBER 16/18.218 The protein and RNA
were represented with the ff14sb and OL3 force field, respectively.136,137 Zinc and its coordinated
Cys and His residues were modeled with the Zinc AMBER force field (ZAFF).147 All systems
were solvated with a 20 Å rectangular box of TIP3P water. SHAKE constraints were applied to
bond lengths to hydrogen atoms. Models were initially heated and equilibrated with constant
volume and temperature from 0 to 300 K using Langevin dynamics. The models were then
equilibrated in the NPT ensemble, followed by multi-microsecond production simulations.

Table 5. Protonation states of His residues outside the Zn2+ coordination sphere (neutral (n)
or protonated (p)) and timescales of MD simulations

reduced ZF456 (redZF456) 5S RNA
redZF456

oxidized ZF456 (oxZF456)

oxZF456 - 5S RNA

H108

H119

H139

MD time (μs)

p

p

p

12

p

p

p

30

n

n

p

30

p

p

p

30

n

n

p

30

p

p

p

30

n

n

p

30

Hydrogen bond analysis using geometric criteria (acceptor-donor distance ≤ 3.3 Å and
angle ≥ 135°) was performed on the complex for comparison to available experimental data.
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(Table A1). The Define Secondary Structure of Proteins (DSSP) algorithm293 was used to
estimate the secondary structure propensities of the oxidized ZF456 peptides throughout the
simulation. Additional trajectory analysis of MD trajectories was conducted using the
TimeScapes package of Python routines.158,294,295 This method identifies residues that move more
quickly than the global dynamics of the biomolecular system by determining pairwise contact
events and hinge motions in the backbone. In this approach, the trajectory is analyzed in terms of
coarse-grained sidechains rather than Cα motion as in the traditional root-mean square deviations
(RMSD). The rates, or activities, of pairwise contact and hinge-pivot events were determined
using a crossing buffer of 6.0–7.0 Å. Trajectories were preprocessed by stripping the solvent,
hydrogens, Zn2+ ions, and RNA, if present, and culling trajectories by extracting frames at 10 ns
intervals. RMS fluctuations were calculated using sliding windows of 10 and 25 frames. Contact
residue and hinge-pivot activity were evaluated by Pearson projection using 10 and 25 siding
windows. Additional details on the TimeScapes routines and their application can be found at
http://www.timescapes.biomachina.org/. Images were created with VMD version 1.9.3296 and
PyMol version 2.3.4297.

Results and Discussion

MD simulations of the reduced ZF456 - 5S RNA complex
The reduced Zn2+-bound ZF456–5S RNA complex is stable over 12 μs with minor
conformation changes occurring during the first half of the simulation (Figure 22A, B) similar to
previous 50 ns simulations of a ZF456 – 61mer 5S RNA initiated from the crystal structure
(PDB: 1UN6).28 The ZF456-RNA interactions found in the MD simulation are generally
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consistent with NMR studies.287 For example, the 117KKHNQ121 sequence at the beginning of the
ZF4 α-helix (Figure 21C) and Lys123 recognize loop E through electrostatic interactions with
the ribose and the phosphate backbone (Table A1). Hydrogen bonding between the Asn120
backbone and O6 of G26 is significantly populated (~83%) in simulations and supported by
additional interactions between the sidechain and the phosphate of G41 and A42 (~7-23%). The
His119 backbone donates a hydrogen bond to the G26 N7 atom (~91%) (Figure 23). However,
the low population of the hydrogen bond between His119 sidechain and G41 nucleobase (~1112%) suggests that it may not be structurally important in agreement with the X-ray structure290.
While the NMR data suggest a potential hydrogen bond network involving the η-hydroxyl of
Tyr105, the 2՛ hydroxyl of G26, and O6 of G41, which is disrupted by a Mg2+ ion in the crystal
structure, this interaction has an insignificant population (<3%) in the current simulations.
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Figure 22. Analysis of the ZF456-5S RNA trajectory. (A) RMSD for ZF456 calculated in terms
of Cα. (B) Radius of gyration for ZF456 and 5S RNA. (C) Comparison of filtering on the RMS
fluctuations using 25 and 10 sliding windows. TimeScapes trajectory analysis of the ZF456
peptide indicates that the highest portion of events prevails in the first half of the simulations
consistent with the RMSD profile for Cα atoms.
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Asn120

Figure 23. Hydrogen bond analysis for the ZF456-5S RNA complex. (A) MD structures and (B)
selected distance measurements for hydrogen bonds that characterize the ZF456-5S RNA
complex. The following hydrogen bond distances are plotted for ZF4, ZF5, and ZF6: His119 BB
– G26 N7, Arg154 SC – U7 PO4, and Thr178 BB – C5 O2, respectively.
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The basic residues clustered primarily in the α-helix of ZF5 (Lys144, Arg151, Lys153,
Arg154, and Lys157) were proposed to interact with the phosphate backbone or ribose hydroxyl
groups of helix V and loop A either electrostatically or via hydrogen bonding.287 In MD
simulations, the Arg154 sidechain forms the most populated hydrogen bonds with the phosphates
of A6 and U7 in loop A (29-60%, Figure 23, Table A1). The Arg151 guanidine intermittently
hydrogen bonds (<28%) with the U20 and G21 phosphates of helix V but seldom interacts with
loop A, in contrast to previous MD simulations.268 Lys157 and Lys144 ε-amino groups form
transient hydrogen bonds with the phosphate groups of A6 (or nucleobase) and C19, and C4 and
C5, respectively (Table A1). In addition, low-population (~19%) hydrogen bonding between the
NδH of His155, the first Zn-coordinating histidine in ZF5, and the phosphate of C5 is consistent
with NMR observations287. However, Lys153 does not participate in any structurally relevant
intermolecular hydrogen bonding (<0.2%) despite its proximity to helix V and loop A in NMR
studies287.
ZF6 interacts with three out of four residues of loop A (5CAUA8) 5S RNA through
Tyr162 in addition to Trp177 and Thr178 of the TWT motif (Figure 23, Table A1) in partial
agreement with experimental results.287,290 Tyr162 also donates a hydrogen bond to the A6
phosphate in addition to accepting a hydrogen bond from the C5 ribose as observed by NMR.
Trp177 backbone and sidechain hydrogen bond with the C5 and A8 riboses, respectively. The
flanking Thr residues, Thr176 and Thr178, donate one and three hydrogen bonds, respectively, to
the N3 and O2 atoms of the C5 base in good agreement with the ZF456-5SRNA crystal
structure290 (Figure 23). Thr176 SC’s interaction with N3 of C5 was not described in the NMR
structure probably due to its intermittent nature (the acceptor-donor distance is ≤ 3.3 Å in only
~30% of the frames). The Thr176 OγH – C5 N3 distance is maintained within 4.5 Å over the

72
simulation so it can be classified as a native contact consistent with previous MD simulations.268
Therefore, the ZF456-5S RNA complex relies on fourteen key hydrogen bond interactions
(Table A1) which are individually populated for at least 40% of the frames. Half of these bonds
involve ZF6, which emphasizes its critical role in 5S RNA binding to TFIIIA.

MD simulations of the free reduced ZF456
MD simulations were performed to determine the conformation dynamics of the free
ZF456 peptide. Because NMR studies indicate that His119 becomes protonated upon RNA
binding, separate simulations were performed with His119 in the neutral (ZF456n) and
protonated (ZF456p) states. While individual ZF domains remain rigid during simulations as
previously reported,268 the overall ZF456 peptide undergoes significant conformational change
(RMSD of ~4 to 16 Å, Figure 24A) due to the reorientation of the ZF regions consistent with the
experiment.268,298 In the TimeScapes trajectory analysis, the transition regions between
conformations yield the largest number of events (Figure A2). Pivot angles of the linkers and
adjacent residues dominate the hinge-bending motions, confirming the localized nature of the
rearrangements and the stability of the Zn2+-bound ββα-fold (Figure A2). While the ZF4-ZF5
linker (130TQQLP134) folds to cap the C-terminus of ZF4 α-helix upon RNA binding, the Phe127Gln131 hydrogen bond and hydrophobic packing between Phe127 and Leu133 that stabilize the
cap become disrupted in free ZF456 (Figure A3) due to ZF5 reorientation. As a result,
hydrophobic residues (e.g., Leu148) critical for DNA binding are exposed allowing the peptide
to adopt conformations compatible with interactions with both nucleic acids.268 The Gly161
linker between ZF5 and ZF6 hydrogen bonds to Lys157 which stabilizes the linker structure
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together with the hydrophobic packing of Val158, Tyr162, and Thr176.287 In the absence of
RNA, the hydrogen bond is weakened and the hydrophobic packing disrupted (Figure A3).

Figure 24. Analysis of trajectories of the free ZF456. (A) RMSD for ZF456p and ZF456n
calculated in terms of Cα atoms. The average RMSD for individual ZFs is ~1-2 Å. The asterisks
(*) indicate the time at which the key structures shown in Figure 25 are taken. (B) Radius of
gyration and (C) RMSF of C for the simulation of ZF456n and ZF456p. RMSF for ZF456
bound to RNA are significantly less mobile by comparison. The linker residues are in gray boxes
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to help distinguish between individual ZF domains. (D) ZF456p structure at 20 μs showing
interactions between ZF4 residues at position -1 and +1 and ZF6 C-terminus residues.

Figure 25. Superimposed (A) ZF456p and (B) ZF456n structures of key conformations, taken at
24, 30, and 20 μs (p) and 24.2 and 28 μs (n). The conformations of ZF4 were fitted to the NMR
structure (gray).
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A long-lived conformation of ZF456p detected at ~17 μs coincides with the closing of the
interface between ZF5 and ZF6 (Figure 24 and A4). An inverse interdomain motion (opening of
the ZF5-ZF6 interface) was previously observed during the short MD simulations.268 Here, the
structural organization is accompanied by a sharp decrease in events (Figure A2) and relatively
high RMSD values (Figure 24A). This conformation is stabilized by hydrogen bonding
interactions between ZF4 α-helix residues at positions -1 (Lys118) and +1 (His119) and ZF6 Cterminal residues Ala185, Gln189, and Asn190 (Figure 24D). An additional hydrogen bond
between His139 and the ZF5-ZF6 linker residue Gly161 contributes to a ~30% decrease in the
protein’s compactness (Figure 24B). This conformation is unstable because ZF45 rotates around
Gly161 breaking compactness-promoting hydrogen bonds and increasing protein’s radius of
gyration as it searches for a more favorable conformation for nucleic acid binding. During the
last several microseconds, ZF456p appears to alternate between two conformations (Figure 24B
and 5), ZF456p-A and ZF456p-B (i.e., at 24 and 30 μs, respectively) as does ZF456n (i.e.,
ZF456n-C and ZF456n-D at 24.2 and 28 μs, respectively). The conformations ZF456pA/ZF456n-C and ZF456p-B/ZF456n-D are similar between the protonation states (RMSD ~2.4
Å) and rely on a moderate conformation change at the ZF5-ZF6 interface. Regardless of the
protonation state of His119, the highest molecular motion occurs within ZF4 (Figure 24C),
particularly at the fingertip of the ββα-fold known to interact with RNA (117KKHNQ121) in
agreement with trajectory analysis using the TimeScapes package (Figure A2). The least
mobility is observed for the β-hairpin of ZF5 and ZF6 and His residues in the Zn2+ coordination
sphere.
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Figure 26. Analysis of the free oxidized ZF456 trajectories. (A) RMSD of Cα for oxZF456p and
oxZF456n. Comparison of (B) radius of gyration and (C) RMSF of C for the simulation of
oxidized ZF456 and reduced ZF456 peptides. (D) Structure of ZF456 at t = 0 μs. Snapshots from
the simulation of (E) oxZF456p and (F) oxZF456n, all three ZFs lose the β-fold completely
during the simulation. The ZFs are depicted as cartoon and colored in cyan (ZF4), blue (ZF5),
and orange (ZF6).

MD simulations of the oxidized free ZF456
Oxidized ZF456 peptides are more conformationally dynamic relative to the free Zn2+bound peptides (Figure 26A). For oxZF456p significant changes in the ZF4-ZF5 interface occurs
before it equilibrates and widely opens at ~10 μs (Figure A5). ZF4 starts to slowly fold over ZF5
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after approximately another seven microseconds, reducing the protein’s gyradius (Figure 26B,
E). The interface between ZF5 and ZF6 adjusts to a new position as a result of a bent within the
ZF5 α-helix (after His155). In contrast, oxZF456n becomes globular earlier in the simulation.
Association of ZF5 and ZF6 and extension of the TQQLP linker to allow ZF4 to cap the globular
shape decreases the protein’s gyradius by ~35 % (Figure 26B, F). This conformation is stabilized
by interdomain (i.e., Trp180 SC – Glu156 BB and Lys123 BB – Glu161 BB, 93% and 40%
population over the last 12 μs, respectively, Figure A6) and intradomain (with a population as
high as 94% for Pro163 BB – His188 BB) hydrogen bonding interactions. As a result, the
hydrophilic residues in oxZF46n, but not in oxZF456p, are facing toward the peptide’s interior in
contrast to a typical/”true” globular structure where these residues are generally surface exposed.
However, the key hydrophilic residues for 5S RNA binding are located at the surface but are not
positioned to interact properly.
The individual ZF domains of oxidized ZF456 undergo various degrees of unfolding due
to the loss of the structural Zn2+ ion. These conformational instabilities are reflected in the
overall delocalized hinge-pivoting fast motions of the oxidized peptides, in contrast to the
reduced ones (Figure A2). In oxZF456p, ZF4 and ZF6 which recognize the 5S RNA loop E and
A, respectively, reach equilibrium RMSD values of ~7.0 Å. ZF4 loses most of its ββα-fold
consistent with its large hinge-bending motions identified in the TimeScapes trajectory analysis
(Figures A2 and A7). ZF5 deviates least from the reduced structure (RMSD ~ 3.5 Å) attributed
to a decrease in α-helicity. Meanwhile, ZF6 loses its β-folds containing the key Tyr162 residue
and increases its α-helical region toward the N-terminus to Gly174 from β-sheet (Figure A7). In
oxZF456n, where His119 is in the NMR-suggested protonation state for the unbound protein,287
all three ZFs undergo significant structural change (RMSD of ~6–8 Å). The β-hairpin in ZF4 and
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ZF6 unfolds completely, and the α-helix content is diminished at the termini where key RNAbinding residues (i.e., His119 and Trp177) are positioned. ZF5 retains half of its β-folds intact
but loses its α-helical structure whose residues would interact with the RNA phosphate backbone
(Figure A7).

MD simulations of the oxidized ZF456 - 5S RNA complex
To determine how disulfide formation and loss of Zn2+ could affect the ZF456 interaction
with RNA, simulations were initiated from a bound conformation of the reduced Zn2+-bound
ZF456 – 5S RNA complex (PDB: 2HGH). Over the course of 30 μs simulations, the oxidized
ZF456 peptides oxZF456n and oxZF456p lose the stabilizing hydrogen bonds that bind the
reduced peptide to RNA. As a result, both peptides become more elastic in their interactions with
RNA with oxZF456p experiencing fewer conformational changes compared to oxZF456n
(average RMSD = ~5 Å vs ~10-11 Å, Figure 27B). ZF4 in oxZF456p loses its β-hairpin and a
half-turn of the α-helix but becomes stabilized by new hydrogen bonds between the Met104 and
Val106 BBs and Gln126 SC. ZF4 residues lose their secondary structure to dominate the hingebending motions of oxZF456p peptide (Figure A8 and 28D). ZF5 retains its ββα-fold whereas
the ZF6 C-terminus residues partially lose their α-helical structure (Figure A8). However, the
hydrogen bonds within the β-hairpin of ZF5 and ZF6 are present throughout the simulation.
Consistently, oxZF456p’s radius of gyration decreases by up to 8% in the first 10 μs of the
simulation before returning to its initial compactness by the 15th microsecond (Figure 27C). On
the other hand, oxZF456n continuously rearranges such that no long-lived conformation is
detected during the 30-μs simulation. OxZF456n’s compactness is similar to oxZF456p during
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the first ~19 μs, but it fluctuates significantly afterward for radii of gyration ranging from 15.1 Å
(-22 %) to 22.0 Å (+14 %) (Figure 27C).

Figure 27. Analysis of the oxidized ZF456 trajectories in the presence of 5S RNA. (A) RMSF of
C, (B) RMSD of Cα, and (C) radius of gyration for the simulation of oxidized ZF456.
Comparison of the (D) native-ness and(E) nonnative-ness Q-values of the reduced and oxidized
ZF456-5S RNA.

80

Figure 28. TimeScapes trajectory analysis of reduced and oxidized ZF456 in the presence of 5S
RNA. (A) Comparison of filtering on the RMS fluctuations using 25 and 10 sliding windows.
(B) Event detection activity determined by cutoff- (6.0–7.0 Å crossing buffer) screening using
the 25-frame screened trajectory. (C) Contact residue and (D) pivot angle activity determined by
Pearson projection using 25 and 10 sliding windows.

TimeScapes trajectory analysis detected greater event activity in the simulation of
oxZF456n than oxZF456p consistent with the trends in RMSD (Figure 28B). The RMS
fluctuations profile of oxZF456n (Figure 28A) reflects the dynamic nature of the peptide starting
at ~19 μs associated with loss of the ZF5 β-hairpin (Figure 27C and A8). ZF4 in oxZF456n
succeeds at maintaining almost intact its ββα-fold (one intra-strand hydrogen bond is lost)
coinciding with low RMSD (~2 Å), contact residue, and pivot angle activity (Figure A9 and 28C,
D). The α-helical content of ZF5 drops early in the simulation, whereas the β-sheet is retained for
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the first ~19 μs. ZF6 undergoes a high degree of unfolding, reflected in the contact residue
activity and associated with rearrangement of residues at positions -3, -2, and -1 from β-strand
(Gly174) or bend (Arg175 and Thr176), respectively, into a destabilized α-helix (Figure 28C and
A8). Both oxZF456p and oxZF456n follow different trends in RMSD profiles of individual ZFs
(Figure A9). In the former, ZF4 is the most flexible (RMSD ~ 4.5 Å at equilibrium), followed by
ZF6 which adopts fewer conformations. The RMSD for ZF5 stays constant and averages ~1.3 Å
over the simulation. For oxZF456n, ZF5 and ZF6 fluctuate significantly with RMSD values up to
12.0-14.0 Å, while ZF4 remains constant similar to ZF5 in oxZF456p averaging ~1.8 Å.
These conformation changes shown in RMSD profiles (Figure A9) are related to the
disruption of most key hydrogen bonding interactions between ZF456 and 5S RNA upon
disulfide bond formation (Table A1). In oxZF456p, the hydrogen bonds between RNA and ZF4
and ZF5 drastically weaken over the first 12 μs (the population drops by 28-74%). ZF4 retains
the His119 BB – G26 N7 hydrogen bond (although the population drops by 54.9%). The loss of
Asn120 BB interaction with G26 O6 at ~6.0 μs is compensated with the formation of new ones
between Asn120 SC and adjacent Lys and loop E/helix V phosphate backbone (~40-48%
population during the first 12 μs, Table A2). Within ZF5, Arg154 guanidine loses its interactions
with A6 but retains those with the U7 phosphate. The disruption of the hydrogen bonds between
ZF5 and RNA phosphates is due to the shift of ZF5 relative to the RNA than to any
conformational variations within this finger. In contrast, ZF6 loses only one out of the seven
hydrogen bonds present in the reduced Zn2+-bound form (Table A1). The interaction between
Thr178 OγH and C5 O2 strengthens by 36% (89.5% vs 65.8% population) at the expense of the
Thr178 OγH - C5 N3 bond, which forms in 50% fewer frames in comparison with the reduced
system. During the last 12 μs, all key hydrogen bonds are lost (Table A1). The base-specific
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interactions of ZF4 and ZF6 with loop E and A, respectively, are replaced by nonspecific
interactions. For example, ZF4 Lys residues, Tyr105 and Gly113 BB hydrogen bonds to loop E
and the adjacent RNA helixes (Table A2). His119 and Asn120 form interactions of <40%
population with G26 N7 and U23 phosphate, respectively. Arg residues within the shifted ZF5
make contacts with the helix V phosphate backbone. ZF6 Trp177 and Thr178 backbones interact
with the A6 phosphates throughout at least 85% of the last 12 μs and each side chain forms a
highly populated interaction with loop A C9 sugar (76.9%) and A6 phosphate backbone (96.6%),
respectively (Table A2).

Figure 29. Snapshots from the simulation of (A) oxZF456p - 5S RNA and (B) oxZF456n - 5S
RNA. The three zinc fingers are depicted as cartoon and colored in cyan (ZF4), blue (ZF5), and
orange (ZF6). 5S RNA is shown in tan.
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In ox-ZF456n, ZF4 retains its hydrogen bonds with G26 and maintains the RNA binding
through multiple nonspecific interactions from the sidechain of Lys117, Lys123, and Gln121 to
loop E/helix V (Tables A1 and A3) during the first 12 μs. In contrast, the population of all key
hydrogen bonds between ZF5 and ZF6 and loop A decline by ~30-61% over the course of the
first 12 μs. Only Arg154 in ZF5 forms new interactions with the loop A phosphate backbone,
though with different groups than in the reduced environment (Nη1H and Nη2H vs Nη2H and
NεH). Additionally, several transient hydrogen bonds develop between Arg and Lys residues and
loop A/helix V to support the RNA binding by ZF5. ZF6 residues do not form new interactions
with 5S RNA to compensate for the weakening of its key hydrogen bonds in the first 12 μs
(Tables A1 and A3). In contrast to oxZF456p, ZF6, not ZF4 undergoes the greatest
conformational changes and loses the most hydrogen bonds (Table A1 and Figure A9). Over the
last 12 μs, the population of key His119 BB – G26 N7 interaction decreases to ~62% (vs 91%)
but the Asn120 BB – G26 O6 hydrogen bond strengthens (~%97 vs ~83% population). All
interactions of ZF4 newly formed in the first 12 μs are maintained throughout the simulation.
Additionally, three hydrogen bonds between Lys114, Asn120, Gln121 SC and loop E/helix V
contribute to >40% of the frames (Table A3). ZF5 and ZF6 lose their key hydrogen bonds to the
loop A phosphate and nucleobases, respectively by the end of the simulation (Table A1). The
side chains of Lys and Arg residues within the α-helix of ZF5 form nine highly populated
hydrogen bonds with the phosphate backbone of loop A/helix V that are not found in the reduced
peptide – RNA complex. Within ZF6, new interactions involving Tyr162 and two residues
within the β-turn, Lys166 and Asp167, are established with loop A and helix V instead (Table
A3). Presumably, these three hydrogen bonds assist the other two ZFs in maintaining RNA
bound to the ZF456 peptide. Disulfide formation and Zn2+ loss forces ZF6, the important finger
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for RNA binding, to lose its secondary structure and ability to interact with RNA. In contrast,
despite losing the proper ββα fold, ZF5 can still play its role as a spacer-element in the RNA
binding process. ZF5 non-specific but secure interactions may allow ZF4 to lock in place and
maintain its base-specific interactions despite being partially unfolded (Figure 29B and A8).
To gain a broader understanding of the interactions between oxZF456 and 5S RNA, the
native contacts were tracked for the course of the simulations for comparison with the reduced
Zn2+-bound RNA complex. Any protein-RNA contact within 4.5 Å in the initial (NMR) structure
was defined as a native contact. Any new protein-RNA contact meeting the distance cutoff (4.5
Å) that formed during the simulations was defined as non-native. Using the initial number of
these contacts, the fraction of (non)native contacts or Q-(non)nativeness was calculated
throughout the simulations (Figure 27D, E). The oxZF456p peptide loses approximately 20% (in
comparison to reduced ZF456p) of native contacts with RNA after 6 μs coinciding with the first
significant reduction in its compactness (Figure 27C, D). An additional ~20% of contacts are lost
at 17.5 μs when a short-lived conformation, defined by RMSD of the highest values and radius
of gyration at a local minimum, is detected. The native contacts of oxZF456n are gradually lost
in the first 8 μs followed by a rapid decline of 30% consistent with a sharp increase in RMSD
(Figure 27B, D). Despite failing to retain most native contacts, both oxZF456p and oxZF456n do
not dissociate from RNA over the timescale of the simulation (Figure 29) due to the increase in
non-native contacts (Figure 27E) and non-specific hydrogen bonds throughout the simulations.
Full dissociation might be observed over longer time scales given a solvent box capable of
accommodating separated ZF456 and RNA.
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Conclusions
ZFs are an important class of proteins that participate in the regulation of several cellular
processes. Targeting ZF proteins involved in the survival and progression of cancer cells or part
of viral replication and transcription mechanisms is a promising strategy for cancer treatment or
viral inhibition. Multi-μs MD simulations examined the effect of Cys oxidation on ZF proteins
and the interaction of oxidized ZFs with nucleic acids at the atomistic level. The central zinc
finger sequence (ZF456) of TFIIIA interacting with 5S RNA was used as a model for this study
and two sets of protonation states were included for the His residues outside the Zn2+coordination sphere.
In the absence of RNA, the reduced ZF456 peptides undergo conformational changes
involving the linker and adjacent residues as shown by trajectory analysis. Individual ZF
domains remain rigid and the ββα-fold intact, but the interactions within the linker structures
(130TQLLP134 and Gly161) are disrupted. Additionally, a long-lived compact conformation of
ZF456p detected about halfway through the simulation and characterized by interdomain
hydrogen bonding is incompatible with nucleic acid binding. Potential pH dependence in the
conformation dynamics of reduced ZFs could be addressed through explicit solvation constant
pH MD simulations. However, late in the simulation, ZF456n and ZF456p alternate between two
conformations consisting of an extended chain of ZF domains compatible with both 5S RNA and
DNA binding.
Upon Zn2+ loss and disulfide bond formation, conformational dynamics within the free
oxidized ZF456 peptides increases considerably to populate conformation incapable of RNA
recognition. The interfaces between ZF domains in oxZF456p fluctuate significantly prior to ZF4
folding over ZF5 and ZF6 adopting a new position relative to ZF5. However, the ZF domains in
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oxZF456n associate into a globular structure early in the simulation assisted by highly populated
inter- and intra-domain hydrogen bonds (i.e., Trp180 SC – Glu156 BB and Pro163 BB – His188
BB. The individual ZFs unfold in both peptides to various degrees resulting in delocalized hingepivoting fast motion. Most of the ββα-fold unravels in fingers that make base-specific
interactions with RNA – ZF4 and ZF6, but ZF5 loses only the α-helix which forms the nonspecific interactions. Due to this unfolding, the peptides lack the secondary structure to recognize
nucleic acids.
In the reduced Zn2+-bound ZF456-5S RNA complex, the hydrogen bond analysis agrees
well with the experimental data showing that ZF456 uses Tyr162, Trp177, and Thr178 in ZF6
(seven hydrogen bonds), Arg154 in ZF5 (three hydrogen bonds), and His119 and Asn120 in ZF4
(four hydrogen bonds) to interact with the 5S RNA. However, some variations from the
experimental results are found. NMR-suggested interactions of ZF4 with G41 and ZF5 Lys
residues with helix V/loop A appear transiently in the MD simulation and may not be relevant to
the 5S RNA binding of TFIIIA. Also, Arg151 does not make hydrogen bonds with loop A as
seen in the previous short MD simulations, but an interaction between ZF6 Tyr162 and the A6
phosphate appears to be important to the binding. The X-ray proposed interaction between
Thr176 SC and C5 N3, but absent in the NMR studies, forms intermittently throughout the
simulation. Disulfide formation and Zn2+ loss diminish the ability of the oxidized ZF456 peptides
to recognize RNA. All ZF domains except ZF4 in oxZF456n lose key hydrogen bonds and native
contacts found in the reduced Zn2+-bound ZF456-RNA complex consistent with reduced binding
affinity and impaired recognition. This loss of key protein – RNA interactions and the
conformational flexibility of the oxidized peptide demonstrate the structural importance of Zn2+
to the ZF secondary structure and ZF recognition mechanisms.
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CHAPTER IV
DFT MODELING OF THE PREVENTION OF FE(II)-MEDIATED REDOX DAMAGE
BY IMIDAZOLE-BASED THIONES AND SELONESa

Introduction

Reactive oxygen species (ROS) are byproducts of cellular respiration and act as
messengers at low concentrations.103,299–301 If not controlled, these species damage cellular
components including proteins, lipids, and nucleic acids.208,300,302–307 Lipids and proteins are
rapidly replaced during cellular maintenance, but recovery of lost information stored in DNA is
difficult which makes it a critical biological issue. Despite numerous cellular DNA repair
mechanisms, cumulative DNA damage contributes to aging, Alzheimer’s disease, cardiovascular
disease, and various forms of cancer.308–315 Accordingly, the behavior of free radicals in
biological systems has been a recent area of significant interest.316–318 The most damaging ROS
is the hydroxyl radical ( ·OH)319 produced by Fenton and Fenton-like chemistry between
hydrogen peroxide and transition metal ions such as Fe(II) and Cu(I) (eq. 14).118,320 Density
functional theory (DFT) studies have examined several pathways for Fe(II)-mediated generation
of hydroxyl radicals.321–324
Mn+ + H2O2 → M(n+1)+ + OH- + ·OH

a

(14)

Reprinted with permission from Dreab, A.; Brewer, M.I.; Bayse, C.A. DFT modeling of the
prevention of Fe(II)-mediated redox damage by imidazole-based thiones and selones. J. Inorg.
Biochem. 2019, 193, 9-14. Copyright 2019 Elsevier. The manuscript can be found online at
https://doi.org/10.1016/j.jinorgbio.2018.12.015.
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Metal-mediated ·OH generation is proposed as a major cause of DNA damage and cell
death through apoptosis.325–328 Single-strand break and nucleobase oxidation are commonly
studied types of Fe(II)-mediated DNA damage.329 Fe(II) is believed to travel along the phosphate
backbone to coordinate to DNA at N7 of guanine,330 the most easily oxidized nucleobase.331 The
intermediate product 8-oxo-deoxyguanine is commonly used as an oxidative damage marker
because it can be detected in the femtomolar range.329 Fe(II)-mediated DNA damage occurs
preferentially at certain sequences (i.e., RGGG or RTGR).330,332,333 Lee et al. have shown that
GTGR is also a sensitive sequence for oxidative damage.334 Radical scavengers such as ethanol
and dimethyl sulfoxide inhibit Fe(II)-mediated DNA damage in vitro, by preventing hydroxyl
radical-induced nicking of the phosphate backbone or oxidation of guanine.335 Enzymatic radical
scavenging has limited effectiveness in combating hydroxyl radicals formed in locations too
hindered for effective access by scavenging systems.320,336 As a result, prevention of metalmediated radical formation may be a superior approach to protecting against oxidative
damage.337
In vitro studies have shown that sulfur and selenium compounds protect DNA from
metal-mediated damage.107,124,337–341 Seven of nine selenium compounds tested prevented Cu(I)mediated oxidative DNA damage, while only five inhibited Fe(II)-mediated damage.119–121
Interestingly, only N,N′-dimethylimidazole selone (3Se) prevented significant Fe(II)-mediated
DNA damage within selenium’s biological range (3.2 μM).337 In contrast, eight of eleven sulfur
compounds tested inhibited Cu(I)-mediated DNA damage with IC50 values from 3.34 to 1550
μM, but only three compounds prevented Fe(II)-mediated DNA damage, among which
glutathione inhibited only 23% of damage.337 N,N′-dimethylimidazole thione (3S) inhibited
Cu(I)-mediated damage at a substantially higher concentration than 3Se (IC50: 1550 μM vs. 240
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μM).337 Ergothioneine has shown significant free radical scavenging capacity but has not been
tested for the prevention of metal-mediated DNA damage.342 Overall, sulfur and seleniumcontaining compounds have shown greater inhibition of Cu(I) over Fe(II)-mediated DNA
damage. Thione and selone derivatives are a notable exception with 3S and 3Se about 17.3 and 75
times more effective, respectively, against inhibition of Fe(II)-mediated DNA damage.337
Since scavenging of the short-lived hydroxyl radical by sulfur and selenium compounds
seems unlikely,10,343 metal coordination has been proposed as the primary mechanism by which
these antioxidants prevent DNA damage.118–121 Protection would occur through sacrificial
oxidation of the coordinated thione/selone122,123 rather than through the direct ROS scavenging
observed for a broad range of sulfur and selenium compounds.124–126 Thiones and selones prefer
to coordinate through the zwitterionic resonance form123,124,344–346 which allows these ligands to
be classified as potential π-donors similar to other anionic chalcogen ligands such as thiolates
and selenolates.123,347 The zwitterionic resonance structures suggest that thiones/selones will
have longer C–E bonds than “true” chalcogenones, E will carry a partial negative charge, and the
heterocyclic ring will be partially positive. Thione/selone coordination to Fe(II) results in higher
ligand-based oxidation potentials and significantly more negative Fe(III/II) -derived reduction
potentials indicating that thiones/selones would more easily undergo oxidation.123

Scheme 1. Chalcogenone resonance structures (E = S/Se).
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The effect of thione/selone coordination on the prevention of DNA damage by Fe(II) was
investigated through DFT studies of the free ligands and their complexes with Fe(II) coordinated
to water and guanine. The contribution of the zwitterionic character of the thiones/selones to the
stability of the complexes was analyzed through changes in the C–E bond distances and the
relative energies of ligand substitution. The highest occupied molecular orbital (HOMO)
character of Fe(II) complexes indicates that localization of the electron density on the ligands
rather than the metal provides a potential antioxidant mechanism through sacrificial oxidation of
the coordinated thiones/selones.

Computational Methods

Density functional theory (DFT) optimized geometries were calculated using Gaussian
09164 and the mPW1PW91160,161 exchange correlation functional. Iron was represented by the
Wachters-Hay all-electron basis set.348 The Wadt-Hay relativistic effective core potential basis
set349,350 augmented with diffuse and polarization functions was used for sulfur and selenium.
Carbon, nitrogen, oxygen, and hydrogen basis sets were triple-ζ quality augmented with diffuse
and polarization functions. All structures were confirmed as minima on the potential energy
surface through inspection of their vibrational frequencies. Wiberg bond indices (WBIs)162 and
Natural Population Analysis (NPA) charges were calculated using Natural Bond Orbital (NBO)
version 3.1.163
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Results and Discussion

DFT geometry optimizations were performed on a series of imidazole-based thiones and
selones with increasing methyl substitution (Figure 30). The electron-donating effect of the
methyl groups stabilizes the zwitterionic resonance structure (Scheme 1),123,124,345 resulting in
longer C–E bonds and more negative NPA charges on E for the series of five thione/selone
derivatives (Figure 31a). The average C–E bond increases by 0.014 Å (thiones) and 0.017 Å
(selones) in tetra-substituted compounds compared to 1S and 1Se, respectively. The NPA charge
on E decreases by 0.009-0.016e and 0.007-0.014e with the addition of each methyl group to the
thione and selone compounds, respectively. In general, the sulfur of thione derivatives is more
partially negative than the selenium centers of their selone counterparts (qS(3S) = -0.281e;
qSe(3Se) = -0.261e). However, the Wiberg bond orders of the selones (3Se: WBIC=Se = 1.338) are
smaller than the thiones (3S: WBIC=S = 1.433) indicating that the selenium compounds have a
more zwitterionic character in agreement with previous studies.344,351,352 The HOMOs of
methylated thiones/selones are also destabilized (i.e., 1Se vs 5Se = -0.19934 a.u. vs -0.18564 a.u.)
(Figure 31b), consistent with increased Lewis basicity and stronger metal coordination.

Figure 30. The series of imidazole-based thiones and selones included in this study.
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Figure 31. C—E bond distance vs (A) NPA charge on E and (A) HOMO energy of free ligands.

Inhibition of DNA damage may result from the effect of thione/selone coordination on
the electronic structure and reduction potential of Fe(II) either as aquated ions or coordinated to
guanine. The relative energy of substitution of a water ligand of [Fe(OH2)6]2+ by a thione/selone
according to reaction (15) was calculated to determine trends in the effect of electron-donating
methyl groups on the affinity of L for the Fe(II) center.
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[𝐹𝑒(𝑂𝐻2)6]2+ + 𝐿 → [𝐹𝑒(𝑂𝐻2)5𝐿]2+ + 𝐻2𝑂

(15)

The DFT structures of the [Fe(OH2)5L]2+ (L= thione/selone) complexes were optimized
assuming octahedral coordination and a high-spin Fe(II) center. Previously synthesized Fe(II)thione/selone complexes adopted a distorted tetrahedral coordination geometry, preferred by the
two or more weak-field thione/selone ligands (i.e [Fe(3Se)2Cl2]).123 For thiones/selones
interacting with free Fe(II) at low concentrations, we expect that water, as a small σ-donor
ligand, will fill the coordination sphere at low L substitution and favor 6-coordination. However,
there is some experimental indication of tetrahedrally coordinated disubstituted Fe(II) ions (i.e.,
[Fe(OH2)2L2]2+)(J.L. Brumaghim, personal communication). The optimized structures are
roughly octahedral with E-Fe-Oeq bond angles ranging from 83.4° to 107.3° (thiones) and from
88.2° to 109.1° (selones). [Fe(OH2)5L]2+ complexes with L containing an NH group (i.e., 2S), are
stabilized by intramolecular hydrogen bonding with the oxygen of a water ligand (NL–HL···Oaq)
(Figure 32a). The longer C–E bonds in [Fe(OH2)5L]2+ (i.e., for 3Se: d(C–Se) = 1.893 Å) vs the
free ligand (d(C–Se) = 1.838 Å) are consistent with stabilization of the zwitterionic resonance
form of the thione/selone through coordination to Fe(II).
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Figure 32. Representative intramolecular bonds lengths (Å) in (A) [Fe(OH2)5L]2+, (B)
Fe(OH2)4L2]2+, (C) [Fe(OH2)5G]2+, and (D) Fe(OH2)4GL]2+ complexes (L = 4S/4Se; G = guanine).

Substitution of an aqua ligand by L (15) is more energetically favorable with increasing
methylation and for selone derivatives relative to the thiones (Table 6), consistent with the trends
in the zwitterionic properties of the free ligand. Intramolecular H–bonding (NL–H···Oaq)
stabilizes the complexes more than N-methylation (i.e., compare 1S/1Se and 2S/2Se in Table 6).
Methylation at C-positions while preserving the NL–H···Oaq bond offers a greater stability of ~3
kcal/mol per methyl group (i.e., 4S/4Se versus 2S/2Se, Table 6). Due to this combination of the
effects of hydrogen bonding and methylation, the most stable [Fe(OH2)5L]2+ complexes are those
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of 4S/4Se rather than 5S/5Se, the most zwitterionic free ligands. 4S/4Se have the shortest Fe–E
bonds, while 3S/3Se and 5S/5Se have the longest due to the steric bulk of the ligand.
[𝐹𝑒(𝑂𝐻2)5𝐿]2+ + 𝐿 → [𝐹𝑒(𝑂𝐻2)4𝐿2]2+ + 𝐻2𝑂

(16)

Table 6. Relative energies of substitution of water ligands at the Fe(II) center by thione/
selone (L) and guanine (G) calculated from the reactions in Eqs. (15), (16), (18) and (19).a
∆E + ZPE, kcal/mol
Ligand

[Fe(H2O)5L]2+

[Fe(H2O)4L2]2+

[Fe(H2O)4GL]2+

Eq. (15)

Eq. (16)

Eq. (18)

Eq. (19)

thiones
1S

-26.05

-26.24

-20.69

-46.70

2S

-27.14

-29.21

-22.25

-47.17

3S

-27.70

-22.85

-18.65

-43.01

4S

-33.70

-31.72

-26.37

-44.73

5S

-33.53

-25.95

-23.56

-42.08

Selones
1Se

-27.38

-27.21

-21.95

-46.63

2Se

-27.85

-30.27

-23.45

-47.66

3Se

-29.33

-23.58

-21.24

-43.98

4Se

-34.75

-32.34

-27.51

-44.82

5Se

-34.51

-27.30

-25.79

-43.34

a

Eq. (17): ∆E + ZPE = -52.06 kcal/mol
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The IC50 values reported by Brumaghim337 suggest that thiones and selones coordinate to
Fe(II) in varying ratios. The optimized structures of bis-thione/selone [Fe(OH2)4L2]2+ complexes
preserve the distorted octahedral geometry of the Fe(II) center. Complexes with L containing NH
groups are stabilized by intramolecular hydrogen bonds between N–H of one L and the S/Se
atom of the other (Figure 32b) instead of intramolecular hydrogen bonds to water ligands found
in [Fe(OH2)5L]2+. This interaction is the major factor that stabilizes the bis-thione Fe(II)
complexes followed by degree of methylation, such that the order of complex stability (eq. 16)
is: 3S/3Se < 5S/5Se ~ 1S/1Se < 2S/2Se < 4S/4Se. Overall, the substitution of a second L is generally
less energetically favorable than the first due to steric interactions between the ligands.
The replacement of an aqua ligand of [Fe(OH2)6]2+ by guanine (G) (eq. 17) was modeled
to mimic the proposed biological interaction of Fe(II) and DNA.330,333,353,354 The substitution of
G is more favorable than substitution by L in eq. (15) by -17 – -26 kcal/mol (Table 6), due to the
preference of the borderline acid Fe(II) for the borderline nitrogenic base. The optimized
[Fe(OH2)5G]2+ complex has a distorted octahedral coordination and is stabilized by two internal
hydrogen bonds between water ligands and the guanine carbonyl oxygen (Figure 32c). The
energetic favorability of substitution of G over L (eq. 15 vs 17) could suggest that the
mechanism by which thiones/selones protect against Fe(II)-mediated damage may occur after
initial metal coordination to DNA. However, kinetics studies of the relative rates of substitution
would be required to confirm these conclusions.
[𝐹𝑒(𝑂𝐻2)6]2+ + 𝐺 → [𝐹𝑒(𝑂𝐻2)5𝐺]2+ + 𝐻2𝑂

(17)

[𝐹𝑒(𝑂𝐻2)5𝐺]2+ + 𝐿 → [𝐹𝑒(𝑂𝐻2)4𝐺𝐿]2+ + 𝐻2𝑂

(18)

[𝐹𝑒(𝑂𝐻2)5𝐿]2+ + 𝐺 → [𝐹𝑒(𝑂𝐻2)4𝐺𝐿]2+ + 𝐻2𝑂

(19)
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The formation of the tetraaquairon(II) guanine thione/selone complex [Fe(OH2)4GL]2+
was modeled along two possible pathways of initial G or L coordination. Coordination of L to
[Fe(OH2)5G]2+ (18) may be more biologically relevant, since sterics may prevent Fe(II)thione/selone complexes from effectively approaching DNA (modeled by eq. 19). The ∆E+ZPE
of ([Fe(OH2)4GL]2+ complexes by these two pathways follows the trend in the [Fe(OH2)4L2]2+
series. In both di-substituted series, trends are reported for the cis complexes only, which are
more stable than the trans (Table 6 and Figure 32d). The relative energy of substitution of G on
[Fe(OH2)5L]2+ is almost independent of the nature of L, but less favorable than initial
coordination of G in [Fe(OH2)5G]2+ due to steric interactions with L. Fe(II)-guanine
thione/selone complexes are stabilized by two hydrogen bonds from water ligands to the guanine
carbonyl oxygen and, if applicable, one hydrogen bond from water ligand to N-H of
thione/selone. These results may explain the different outcomes of the experimental studies
examining the ability of inorganic selenium compounds to prevent Fe(II)-mediated DNA
damage.355 The lesser protection by inorganic selenium compounds added after incubation of
Fe(II) and DNA may be due to reduced accessibility of the selenium species to the DNA-bound
Fe(II). In contrast, the addition of Fe(II) and selenium species prior to the addition of DNA was
more successful in preventing DNA damage.
Thiones and selones are proposed to prevent oxidative DNA damage by coordinating to
the metal and undergoing oxidation more easily than the metal center.122,356 In this targeted ROS
scavenging,337 the thione/selone ligands sacrifice their electrons to prevent Fe(II) oxidation and
DNA damage. Assuming that electrons will be lost from the HOMO in an oxidative process, we
examined the character of the frontier orbitals of the Fe(II) complexes to understand how
thiones/selones protect against DNA damage. The HOMO of [Fe(OH2)6]2+ is the metal-centered
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eg* orbital with antibonding character between the metal and water ligands (Figure 33). From
these results, we can conclude that aquated (i.e., “free”) Fe(II) ions undergo oxidation at the
metal center consistent with Fenton-type chemistry. In contrast, the HOMO of [Fe(OH2)5G]2+ is
localized on the nucleobase (Figure 33). Therefore, when Fe(II) coordinates to DNA through the
N7 of guanine, damage may occur by direct oxidation of the metallated nucleobase. Likewise,
the HOMOs of [Fe(OH2)5L]2+ are similarly ligand-based and localized on an E-type lone pair of
the thione/selone (Figure 33).
Therefore, in agreement with the previous modeling of Cu(I) complexes of
thiones/selones,122,337 the ligands would be preferentially oxidized to protect the iron center.
[Fe(OH2)4L2]2+ complexes maintain the same HOMO character as the mono- complexes, being
predominately composed of delocalized p orbitals of the two L ligands (Figure 33). So, bisthione/selone Fe(II) complexes are similarly predicted to oxidize at L in preference to the Fe(II)
center. In the model of the L-protected Fe(II)-guanine complex [Fe(OH2)4GL]2+, the HOMO is
also L based with similar to the [Fe(OH2)5L]2+ complexes (Figure 33). As a result, protection of
DNA from Fe(II)-mediated oxidative damage is consistent with a mechanism of secondary
coordination of a thione/selone ligand which is preferentially and sacrificially oxidized over
Fe(II) or the nucleobase. The hydroxyl radical scavenging capacity of ergothioneine,342 a thione
similar to the ligands in this study, may be due to a similar shift in HOMO character if metal
coordination is involved in the prevention of ROS production. Given the smaller field splitting in
tetrahedral coordination, the same trends in HOMO character are expected if Fe(II) species are
four-coordinate rather than the six- as modeled.
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Figure 33. HOMOs of the representative Fe(II) complexes. 3Se was chosen as an example for all
Fe(II)-L complexes, since the HOMOs of the thione complexes have the same character as the
selones.

Conclusions

DFT calculations were performed for a series of thione/selone derivatives as free ligands
and coordinated to aquated Fe(II) ions. The zwitterion character of the selone/thione ligands
increased with substitution of electron-donating methyl groups, as shown in longer C–E bonds in
the free ligand and more energetically favorable complexes with Fe(II). Selone derivatives have
more zwitterionic character and coordinate more strongly to Fe(II), consistent with their greater
effectiveness against Fe(II)-mediated DNA damage experimentally. Examination of the HOMO
of the Fe(II) complexes indicates that Fe(II) binding to guanine makes the DNA more prone to
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oxidative cleavage. However, the localization of the HOMO character of the Fe(II)-guanine
complex changes upon thione/selone coordination from nucleobase- to thione/selone-centered.
This shift in character is consistent with preferential oxidation at the thione/selone and protecting
the metal and nucleobase. However, unlike other biochalcogen-based antioxidants, this
protection is non-catalytic and DNA damage would be expected to resume once thiones/selones
are exhausted unless the process could be coupled with a reductant. This modification explains
the antioxidant activity of S/Se compounds in preventing Fe(II)-mediated redox DNA damage.
Although our modeling has focused on six-coordinate complexes of Fe(II), the same trends are
expected if the metal prefers tetrahedral coordination.
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CHAPTER V
CONCLUSIONS
In this dissertation, computational methods were employed to address three different
aspects of metal ions in biology. First, MD simulations were used to model the ability of Ni2+bound piscidins 1 and 3, naturally occurring antimicrobial peptides, to insert and induce
structural changes to lipid bilayers in the presence and absence of oxidized lipid species. Upon
metallation, P1:Ni2+ and P3:Ni2+ insert the N-termini deeper into the membrane and modify their
orientations (τ and ρ) to enhance the hydrophobic and electrostatic interactions. The insertion of
the ATCUN- Ni2+ complex is aided by the partial shielding of the metal center by His4
coordination or aromatic sidechains. The membrane reacts to the peptide insertion by slightly
increasing the hydrophobic thickness and the packing order of the lipid chains. In the presence of
10% aldo-PC, the lipid bilayer thins, reduces the interactions between the PC and PG
headgroups, and increases the disorder of acyl chains. These changes are indicative of potential
disruption of membrane bulk properties. P1:Ni2+ increases its hydrogen bonding interactions
with the PG headgroups in the presence of oxPLs, in agreement with experimental data. Since
deeper insertion and a preferential association with anionic headgroups may promote disruption
of the bacterial membrane, the results of this investigation help explain the enhanced activity in
vitro of metallated peptides in the presence of aldo-PC.
Second, multi-microsecond MD simulations were employed to study the effects of
cysteine oxidation on ZFs, an important class of proteins that participate in the regulation of
several cellular processes, and the interactions of oxidized ZFs with nucleic acids. The central
zinc finger sequence (ZF456) of TFIIIA interacting with 5S RNA was used as a model for this
study. The individual ZF domains in the reduced ZF456 peptides remain rigid and the ββα-fold
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intact, being compatible with both 5S RNA and DNA binding. Upon oxidation, the free oxidized
ZF456 peptides become considerably more dynamic and adopt conformations incapable of RNA
recognition. The individual ZFs unfold to various degrees with the most ββα-fold unraveling in
fingers that make base-specific interactions with RNA – ZF4 and ZF6. Such unfolded peptides
lack the secondary structure to recognize nucleic acids. The ability of oxidized ZF456 peptides to
recognize and bind RNA is diminished in RNA-bound oxidized ZF456 systems because of the
loss of key hydrogen bonds and native contacts found in the reduced ZF456-RNA complex. The
conformational flexibility of the oxidized ZF456 peptides accompanied by the loss of key protein
– RNA interactions demonstrate the structural importance of Zn2+ to the ZF secondary structure
and ZF recognition mechanisms.
Finally, DFT studies were performed to investigate the prevention of Fe2+-mediated DNA
damage by the coordination of imidazole-based thiones and selones. Substitution of electrondonating methyl groups in a series of thione/selone derivatives yields longer C–E bonds in the
free ligand, hence more zwitterion character, and more energetically favorable complexes with
Fe(II). Since the selone derivatives have elongated C–E bonds and such more zwitterionic
character, they coordinate more strongly to Fe(II). Experimentally, the selones have greater
effectiveness against Fe(II)-mediated DNA damage than the thione counterparts. Upon
thione/selone coordination the HOMO character of the Fe(II)-guanine complex shifts from the
nucleobase to thione/selone. This change in HOMO localization is consistent with preferential
oxidation at the thione/selone protecting the metal and nucleobase. These results explain the
antioxidant activity of S/Se compounds in preventing Fe(II)-mediated redox DNA damage.
In future work, extending these computational studies on other metallopeptides and/or
membrane-active peptides that share similar features may help to design novel therapeutics for
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antibiotic-resistant infections. MD simulations of metal-bound piscidins in alternative lipid
mixtures commonly used as bacteria membrane mimics (e.g., 1:1 POPG/POPE) and in the
presence of various amounts (e.g., 25% oxPLs) and products of lipid oxidation (e.g., carboxyl
functionalized PLs) will provide additional characteristics of their mechanism of action including
change in orientation, depth of insertion, preferred lipid constituent for interactions and potential
structural modifications within the bilayer. Additionally, a higher protein to lipid ratio may aid
the comparison between the computational and biochemical data for a better understanding of
the piscidin mechanism of action. MD simulations of ZF proteins interacting with oxidants (e.g.,
reducible sulfur and selenium compounds) will provide mechanistic details to the ZF oxidation
process for the efficient targeting of ZF proteins involved in the survival and progression of
cancer cells or part of viral replication and transcription mechanisms. These investigations may
provide experimentalists with additional means to explain the in vitro/vivo effects of metalbinding (e.g., enhanced antimicrobial activity) or removal (e.g., inhibition of viral replication) to
facilitate the successful and efficient design of novel therapeutics.
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Figure A1. The orientation of the N- and C-terminal ends of the peptide in the bilayer described
by the (A) tilt and (B) azimuthal rotational angles. The tilt angle, τ, defines the orientation of the
helical axis with respect to the bilayer normal (z-axis), and the azimuthal rotation angle, ρ, is the
rotation of the helix around its helical axis.
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Figure A2. Trajectory Analysis of the reduced and oxidized ZF456 in the absence of RNA using
the TimeScapes package. Comparison of filtering on the RMS fluctuations of (A) redZF456 and
(B) oxZF456 using 25 and 10 sliding windows. Event detection activity determined by cutoff(6.0–7.0 Å crossing buffer) screening using the 25-frame screened trajectory of (C) redZF456
and (D) oxZF456. Pivot angle activity in (E) protonated and (F) neutral ZF456 peptide
determined by Pearson projection using 25 and 10 sliding windows.
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Figure A3. Comparison of linkers structure in reduced ZF456 in presence and absence of 5S
RNA. Distance plot of the hydrogen bond within the (A) ZF4-ZF5 and (B) ZF5-ZF6 linker. (C)
Snapshots from the simulations showing the change in the ZF4-ZF5 linker structure interactions
upon RNA removal. The three zinc fingers are depicted as cartoon and colored in cyan (ZF4),
blue (ZF5) and orange (ZF6). The gray spheres represent the Zn2+ ions. The faded conformation
is from the simulation of ZF456 – 5S RNA complex. The structures are best fitted with respect to
ZF4.
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Figure A4. Closing of the ZF5-ZF6 interface seen in the long-lived conformation redZF456p.

Figure A5. Snapshot from the simulation of oxZF456p showing the unfolding of ZF4 and
opening of the ZF4-ZF5 interface.

131

Figure A6. Interdomain hydrogen bonds in the globular conformation of oxZF456n.
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Figure A7. Comparison of the secondary structure modifications of (A) oxZF456p and (B)
oxZF456n in the absence of 5S RNA. The initial secondary structure of each ZF is shown on the
right. Only the residues within the β-hairpin and α-helix are numbered.
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Figure A8. Comparison of the secondary structure modifications of (A) oxZF456p and (B)
oxZF456n in the presence of 5S RNA. The initial secondary structure of each ZF is shown on the
right. Only the residues within the β-hairpin and α-helix are numbered.
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Figure A9. RMSD of individual ZF domains in the simulation of the oxZF56 - 5SRNA complex
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Table A1. Hydrogen bonds with population >20.0% in the simulations of reduced ZF4565S RNA. H-bonds that populated at least 40% of the frames are defined as key and shown in
bold. Hydrogen bonds involving the Lys residues are reported as the sum of up to three
populations (same H-bond acceptor and donor but different H atom).
H-bond
acceptor

redZF456
H-bond donor

0-12 μs

oxZF456p
0-12 μs

18-30
μs

oxZF456n
0-12 μs

18-30
μs

ZF4
G26 b-N7

His119 BB

91.4

41.2

-

72.0

62.0

G26 b-O6

Asn120 BB

82.9

21.4

-

90.7

96.7

A25 s

Lys118 SC

56.2

21.0

5.9

32.4

24.6

G40 p'

Lys123 SC

40.4

13.5

-

80.1

82.7

G41 p''

Lys123 SC

38.9

9.5

-

84.8

92.2

U23 p

Lys117 SC

37.4

10.7

-

29.3

31.0

A25 s

Lys118 SC

30.9

28.1

17.4

12.7

12.5

A42 p

Asn120 SC

23.3

4.0

-

30.1

32.2

ZF5
U7 p'

Arg154 SC-Nη2

59.8

43.0

2.3

35.9

-

A6 p'

Arg154 SC-Nη2

55.6

25.9

-

38.2

-

A6 p'

Arg154 SC-Nε

47.3

31.5

-

21.2

-

U7 p'

Arg154 SC-Nη1

28.7

33.9

7.2

14.6

<1.0

U20 p'

Arg151 SC-Nη2

27.7

34.2

77.8

3.2

-

A6 b-N7

Lys157 SC

27.3

11.9

<1.0

6.9

-

U20 p'

Arg151 SC-Nε

26.5

33.5

-

0.8

-

G21 p''

Arg151 SC-Nη2

26.0

30.2

95.1

2.5

-

A6 p''

Lys157 SC

20.4

9.8

-

7.4

-

ZF6
A6 p''

Tyr162 SC

97.3

95.3

-

55.0

-

C5 b-O2

Thr178 BB

95.7

93.0

-

64.9

-
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Table A1. Continued

H-bond
acceptor

redZF456
H-bond donor

0-12 μs

oxZF456p
0-12 μs

18-30
μs

oxZF456n
0-12 μs

18-30
μs

ZF6
C5 s

Trp177 BB

92.8

95.7

-

65.0

-

A8 s

Trp177 SC

90.6

87.5

-

60.9

-

Tyr162 SC

C5 s

67.5

72.7

-

28.6

-

C5 b-O2

Thr178 SC

65.8

89.5

-

50.6

-

C5 b-N3

Thr178 SC

560

27.9

<1.0

27.8

-

C5 b-N3

Thr176 SC

29.6

20.3

-

10.4

-
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Table A2. Hydrogen bonds with population >40% in the oxZF456p-5S RNA simulation but
absent in the reduced ZF456-5SNA. Hydrogen bonds involving the Lys residues are reported
as the sum of up to three populations (same H-bond acceptor and donor but different H atom).
H-bond
acceptor

H-bond donor

oxZF456p
0-12 μs

18-30 μs

ZF4
G26 p

Lys118 SC

48.1

79.5

U24 p

Lys118 SC

44.3

78.3

U23 p

Asn120 SC

43.5

0.9

G22 p''

Lys123 SC

40.3

0.0

G22 p'

Lys123 SC

2.8

94.5

G40 p'

Tyr105 BB

22.5

91.8

G40 p''

Lys117 SC

20.8

56.8

G39 b-O6

Lys114 SC

11.9

55.1

G41 b-N7

Lys117 SC

24.6

52.3

U38 p

Gly113 BB

11.6

50.5

ZF5
U20 p'

Arg151 SC-Nη1

8.1

97.4

U20 p''

Arg154 SC-Nη1

2.5

84.5

C19 p'

Arg154 SC-Nη1

5.4

80.7

U20 p'

Arg154 SC-Nε

6.7

74.7

G21 p'

Arg151 SC-Nε

0.5

69.3

G21 p''

Ser150 SC

0.3

62.1

C19 p'

Arg154 SC-Nη2

4.0

60.9

ZF6
A6 p''

Thr178 BB

-

97.5

A6 p''

Thr178 SC

-

96.6

A6 p'

Trp177 BB

-

85.1

C9 s

Trp177 SC

-

76.9
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Table A3. Hydrogen bonds with population >40% in the oxZF456n simulations but absent
in the reduced ZF456-5S RNA. Hydrogen bonds involving the Lys residues are reported as the
sum of up to three populations (same H-bond acceptor and donor but different H atom).
H-bond
acceptor

H-bond donor

oxZF456n
0-12 μs

18-30 μs

ZF4
G26 p

Lys117 SC

46.8

50.0

G22 p''

Gln121 SC

44.8

57.5

U24 p

Lys117 SC

43.7

46.2

G22 p'

Lys114 SC

31.9

51.8

G41 p'

Asn120 SC

34.7

47.7

G21 p'

Gln121 SC

32.5

47.7

ZF5
U7 p''

Arg154 SC-Nη1

55.2

98.8

U7 p''

Arg154 SC-Nη2

43.3

93.3

G17 s

Arg154 SC-Nε

18.5

88.2

A6 p'

Arg151 SC-Nη2

24.3

83.4

C18 p

Lys157 SC

3.1

72.0

U7 p'

Arg151 SC-Nη1

23.7

66.3

C19 p''

Lys153 SC

6.7

61.8

A6 p'

Arg151 SC-Nε

23.4

58.5

U7 p'

Arg151 SC-Nη2

25.4

57.2

ZF6
C18 p

Tyr162 SC

-

90.7

C5 b-O2

Lys166 SC

-

42.9

C9 s

Asp167 BB

-

40.8
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